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Abstract 
Murine polyomavirus lytically infects mouse cells, transforms rat cells in culture, and 
is highly oncogenic in rodents.  We have used deep sequencing to follow 
polyomavirus infection of mouse NIH3T6 cells at various times after infection and 
analyzed both the viral and cellular transcriptomes. Alignment of sequencing reads to 
the viral genome illustrated the transcriptional profile of the early-to-late switch with 
both early-strand and late-strand RNAs being transcribed at all time points. A number 
of novel insights into viral gene expression emerged from these studies, including the 
demonstration of widespread RNA editing of viral transcripts at late times in 
infection.  By late times in infection, 359 host genes were seen to be upregulated and 
857 were downregulated.  Gene ontology analysis indicated transcripts involved in 
translation, metabolism, RNA processing, DNA methylation, and protein turnover 
were upregulated while transcripts involved in extracellular adhesion, cytoskeleton, 
zinc finger binding, SH3 domain, and GTPase activation were downregulated.  The 
levels of a number of long noncoding RNAs were also altered.  The long noncoding 
RNA MALAT1, which is involved in splicing speckles and used as a marker in many 
late-stage cancers, was noticeably downregulated, while several other abundant 
noncoding RNAs were strongly upregulated. We discuss these results in light of what 
Seth	  Garren	  – University of Connecticut. 2015	  
	  
is currently known about the polyoma life cycle and its effects on host cell growth and 
metabolism. 
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I. INTRODUCTION 
 
 For over 60 years mouse polyomavirus has proven instrumental in the 
understanding of both viruses from the Polyomaviridae family as well as the endogenous 
host factors the virus utilizes to create the tumorigenic phenotype for which it is named.  
Mouse polyomavirus is a small circular double-stranded DNA virus with a genome that is 
only 5,327 base pairs.  It consists of two divergent transcription units whose products are 
alternatively spliced to produce mRNAs for the large, middle, and small tumor antigens 
at early times and the VP1, VP2, and VP3 viral coat proteins at late times (Fig. 1).  It is 
through the interaction of the tumor antigens that the virus can alter host-signaling 
pathways to drive the cell into S-phase to initiate the DNA replication the virus requires 
in order to copy itself and undergo an early-late switch to begin producing viral coat 
proteins.  This thesis will focus on the biology of the mouse polyomavirus infection with 
respect to both virus and host gene expression.   
 
A. Mouse Polyomavirus Biology 
1. Discovery 
 Mouse polyomavirus was discovered in 1953 when a cell free extract from mice 
infected with a leukemia virus also caused the development of salivary gland tumors 
when inoculated in newborn mice (Gross 1953).   This tumor agent was cultured using 
mouse embryo cells and was called “polyoma” for its ability to produce a variety of 
tumors (Stewart 1958).  The development of a polyoma plaque assay allowed for pure 
strains of virus to be quantified by overlaying an infected monolayer of cells with an agar  
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Figure 1. Map of transcription and splicing in the mouse polyomavirus. 
 
Map of the circular doublestranded DNA genome of the mouse polyomavirus.  Early 
strand transcripts are shown in blue and the late strand transcripts are shown in red.  
Alternative splicing of the early strand produces the Large, middle, and small t antigens 
while the late strand splices into VP1, VP2, and VP3.  Early and late transcripts are on 
opposite strands flanking the noncoding control region, which contains the origin of 
replication (marked as “ori”).  Also shown are the polyadenylation sites which are 
roughly opposite from the noncoding control region on the genome.   
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nutrient mixture and counting the number of plaques that form when the cells lyse 
(Winocour 1959).  Media from polyoma cultures was shown to induce agglutination in 
red blood cells allowing for the hemagglutination inhibition assay to be used to detect 
antibodies against the virus (Eddy 1958) as well as measure the rate of adsorption 
(Crawford 1962A). Antibodies from a variety of mouse colonies showed a positive 
reaction for polyoma, indicating that the virus was already present in many mouse stocks 
independent of strain (Rowe 1959).  By culturing primary cells from the kidneys of 
infected newborn mice, high titers of pure virus could be obtained (Winocour 1963).  The 
development of these techniques made it possible to study the virus in further detail. 
 
2. Characterization 
a. Transformation 
Depending on the type of cells polyomavirus is cultured on, it either undergoes a 
permissive “lytic” infection, where the cells produce large quantities of virus and are 
lysed in the process, or a non-permissive “transforming” infection where the cells take on 
the same tumor phenotype but do not produce virus.   This transformation infection was 
first observed when polyomavirus was cultured on hamster cells (Vogt 1960).  Hamster 
cells transformed by polyoma could be passaged and caused tumors when injected into 
live animals but showed no evidence of virus production (Habel 1960, Vogt 1962). 
Despite this lack of apparent virus production, antibodies to a tumor antigen of viral 
origin could still be detected in the sera from animals injected with transformed virus-free 
tumors when it was exposed to cell extracts from both mouse and hamster cells infected 
with polyomavirus (Habel 1965).  In addition, pulse labeled RNA from transformed cells 
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showed hybridization to viral DNA (Benjamin 1966). Taken together, these experiments 
suggested that viral gene products were still present in the transformed cells.  
Experiments with polyoma and a similar primate virus SV40 showed transformed cells to 
contain viral DNA integrated into the host genome (Sambrook 1968).  Exposure of 
polyoma to DNA damage via radiation before infection showed that the lytic infection of 
mouse cells is roughly twice as sensitive to radiation compared to the transformation of 
hamster cells, indicating roughly half of the viral genome is required for transformation 
(Basilico 1965, Benjamin 1965, Laterjet 1967). Viral mutants were isolated that lost the 
ability to grow in permissive mouse cell lines but could grow when cultured in mouse 
cells that had already been transformed by a previous abortive polyoma infection 
(Benjamin 1970).  This indicated that the mutated viral gene products required for 
transformation were provided by the genes integrated in the transformed cell line from 
the previous infection, while the gene products necessary for a complete lytic infection 
were still intact in the mutated virus.  At this point transformation appeared to be 
necessary but not sufficient for a complete lytic infection.  We now know these mutants 
were unable to express middle and small t antigens, which is why they could only infect 
previously transformed cells.  Since the mutants still expressed Large T, VP1, VP2, and 
VP3, they could still replicate, undergo an early late switch, and complete a lytic 
infection. 
 
b. Structure 
 Electron microscopy of polyoma virus particles revealed two types of particles of 
approximately 450 angstrom in diameter, full virus particles and empty capsids (Wildy 
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1960).  While both particles shared the same structure and ability to induce agglutination 
in red blood cells, the two types of particles could be separated based on buoyant density 
by centrifugation in rubidium chloride.  Only the particles in the denser gradient were 
able to infect cells, suggesting that the other gradient contained empty capsids (Crawford 
1962B).  The viral capsids were observed to be composed of 72 subunits or capsomeres 
arranged in an icosohedral structure (Klug 1965, Finch 1974).  When virus particles were 
run on SDS-polyacrylamide gels, 7 distinct polypeptides could be identified, VP1, VP2, 
VP3, and four mouse histone proteins H2a, H2b, H3, and H4 (Frearson 1972, Friedmann 
1972, McMillen 1974, Roblin 1971, Seehafer 1974).  VP1 is the largest and most 
abundant capsid protein at ~48kDa, while VP2 and VP3 are 35 and 23 kDa respectively 
(Hewick 1975).  VP2 and 3 share polypeptide sequence with each other but not with VP1 
(Friedmann 1976).  This is because VP2 and VP3 are contained within the intron of VP1 
(Kamen 1980).    
 
c. Genome 
 Phenol extracted nucleic acid from polyoma infected mouse embryo cultures was 
shown to lose its infectivity upon treatment with DNase but not RNase indicating a DNA 
based genome (DiMayorca 1959).   The polyoma virus genome showed a high resistance 
to boiling and demonstrated spontaneous renaturation (Weil 1963A).  When extracted 
polyoma DNA was separated by velocity sedimentation, it produced components 
consistent with both linear and circular genomes, both of which retained transforming 
ability (Crawford 1964).  Analytical ultracentrifugation of polyoma DNA showed three 
types of sedimentation corresponding to super-coiled closed circlular double helices, 
	  7	  
genomes with a single stranded break, and double stranded linear molecules (Radloff 
1967, Vinograd 1965, Vinograd 1968).  These findings along with electron microscopy 
demonstrated that the polyoma genome is circular and double-stranded (Weil 1963B).  
When polyoma genomes were digested with the restriction enzyme Eco RI that only cuts 
in one place on the genome and treated with the single stranded DNA binding protein 32 
from bacteriophage T4, a single denaturation loop per molecule could be visualized by 
electron microscopy at one of	  three unique sites corresponding to A/T rich regions (Yaniv 
1974).  One of these sites would later be identified as part of the noncoding control 
region.  Electron microscopy of intact nucleoprotein complexes revealed chromatin like 
structures with viral DNA bound to histones (Cremisi 1976).  The first attempts to map 
the polyoma genome used digestion by different combinations of restriction enzymes to  
determine the order the fragments of viral DNA. This subsequently made it possible to 
determine the relative location of restriction sites based on the order of the fragments 
(Chen 1975).  Restriction digestion of partially replicated intermediates (under 50% 
replicated) allowed for the identification of the fragment containing the origin of 
replication (Griffin 1974).  Cleavage of partially replicated intermediates with the 
restriction enzyme EcoRI made it possible to visualize the bidirectional replication of 
polyoma using electron microscopy to determine the relative location of the origin 
(Crawford 1973) and terminus (Crawford 1974) with respect to known restriction 
digestion sites.  Partial denaturation of polyoma fragments from different restriction 
enzymes allowed for mapping of A/T rich regions using electron microscopy (Lescure 
1975).  Using a sequencing method (Maxam 1977) that involves chemically attacking 
specific bases and running terminally radio-labeled DNA fragments on a polyacrylamide 
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urea gel, the regions encompassing the origin and 5’ end of the early region (Friedman 
1978), the early region (Friedman 1979, Soeda 1979), and the late region (Deininger 
1979, Arrand 1980) were sequenced and found to have extensive homology with SV40.  
The sequencing data and restriction maps were combined to make a complete map of the 
polyoma virus genome (Deininger 1980, Soeda 1980). 
 
d. Mutant analysis 
 Attempts to ascertain the functions of the different regions of the polyoma 
genome were aided by the use of two major classes of polyoma mutants, temperature-
sensitive and host range nontransforming mutants.  Temperature-sensitive mutants 
function like wild type at low temperatures (32°C) but lose transforming ability and viral 
DNA synthesis at nonpermissive temperatures (39°C).  Host range nontransforming 
mutants are defective in their ability to transform wild type cells but function normally 
when infecting cells that have already been transformed.  Work with both kinds of 
mutants has revealed a number of major insights into the function of the early and late 
regions of the viral genome as well as the process of transformation by the early genes.   
 
i. Temperature-sensitive mutants 
 In order to isolate temperature sensitive mutants of polyoma, large plaque strains 
of polyoma were treated with nitric acid long enough to reduce viability of the virus to 
between 1 in 10,000 to 1 in 100,000 surviving at 32°C.  Of the surviving plaques 40 were 
replated at both 32°C and 39°C and two temperature sensitive lines ts-a and ts-b showed 
at least a 100 fold difference in plaque formation between 32°C and 39°C (Fried 1965).  
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One of the temperature-sensitive mutants ts-a was found to induce host DNA replication 
but failed to transform the host cell or synthesize viral DNA when cultured at 
nonpermissive temperatures (Fried 1970).   
When ts-a was shifted to a nonpermissive temperature after viral DNA production 
initiated it was found that viral gene products were necessary for the initiation but not 
completion of viral DNA synthesis (Francke 1973).  Assessment of six different 
temperature sensitive mutants that were isolated using similar methods showed three 
kinds of mutations.  At nonpermissive temperatures class I mutants failed at making 
infectious viral particles, class II mutants were unable to transform cells or synthesize 
viral DNA, and class III mutants could transform cells but could not synthesize viral 
DNA.  Mutants unable to synthesize viral DNA were called “early” and mutants that 
make viral DNA but fail to produce virus particles were called “late” (Eckhart 1969).  
Both “early” and “late” mutants were able to induce cellular DNA synthesis (Eckhart 
1971A).  Experiments to determine the cause of the inhibition of cellular transformation 
and viral DNA synthesis found that at nonpermissive temperatures, “early” mutants were 
defective in T antigen expression but “late” mutants were not.  In addition, treatment of 
infected cells with DNA replication inhibitors did not affect T antigen expression in 
either wild type or mutants at permissive temperatures (Oxman 1972).  Late mutants such 
as ts-59 were shown to express altered versions of all three viral coat proteins at 
nonpermissive temperatures that failed to form stable virus particles but could be 
complemented by the functioning coat proteins from early mutants such as ts-a (Gibson 
1977).  Cells infected with temperature-sensitive mutants defective in their ability to 
transform cells at nonpermissive temperatures did not revert to an untransformed 
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phenotype when switched to a nonpermissive temperature (Dimayorca 1969).  This 
indicated that the disrupted viral genes are necessary for the initiation, but not 
maintenance, of the transformed phenotype.   
Another temperature sensitive mutant, ts-3, was used to show that certain 
hallmarks of a transformed phenotype could be rendered temperature dependent.  At 
nonpermissive temperatures, cells infected with ts-3 did not demonstrate a loss of 
topoinhibition, the halting of DNA replication when cells become too dense (Dulbecco 
1970).  In addition, ts-3 renders the reduction in extracellular proteins that normally 
occurs during transformation, temperature dependent (Eckhart 1971B).  The ts-3 mutant 
was also shown to have different sensitivities in different host cell types, failed to 
complement with other mutants, and decreased temperature sensitivity when fresh 
medium and serum was added at a nonpermissive temperature (Eckhart 1974).  When 
RNA from cells infected with ts-3 was annealed to radiolabeled viral early DNA, it failed 
to accumulate at nonpermissive temperatures indicating the temperature sensitivity 
affected early transcription (Cogen 1977).  These observations were likely the result of 
the temperature sensitivity affecting the ability of the ts-3 virus to uncoat and release viral 
DNA at non permissive temperatures.  This explains the lack of transcription as well as 
the lack of transformation hallmarks.   
Taken together these experiments with temperature sensitive mutants demonstrate 
the primary functions of viral genes are to transform host cells, initiate viral DNA 
replication, and produce viral coat proteins.  
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ii. Host range nontransforming mutants 
 Early investigation into polyoma gene function required a way to culture mutant 
virus in order to observe loss of function.  Unfortunately, most viral mutants could not be 
cultured directly since so much of the viral genome is critical for the viral life cycle.  One 
strategy to overcome the problem was the use of temperature sensitive mutants.  Another 
approach was to use what are called host range nontransforming mutants or “hr-t 
mutants”.  Hr-t mutants are unable to grow in normal mouse cells but they can grow in 
mouse cells that have been previously transformed.  When infected with polyoma, mouse 
3T3 cells can undergo both lytic infection and abortive transformation in which some of 
the cells do not produce virus particles but instead integrate viral genes in the host 
genome (Sambrook 1968).  Transformed 3T3 cells that do not produce virus particles can 
be cultured and used as hosts for virus mutants defective in their ability to transform 
cells.   
In order to isolate transformed virus-free cells, mouse 3T3 cells were infected 
with polyoma virus and plated in soft agar suspension to select for transformed cells.  
Antiviral serum and receptor destroying enzyme was added to prevent reinfection of the 
transformed virus-free cells.  This resulted in 9 clones that could be recultured in antiviral 
conditions.  Of these only one clone, 3T3 Py3, was able to be both infected and 
maintained indefinitely.  Polyoma virus was mutagenized with either nitrosoguanidine 
(NG) or hydroxylamine (HA) and cultured on both 3T3 and 3T3Py3 cells.  Out of the 900 
NG and 360 HA plaques tested only 3 NG (NG-18, NG -23, NG-59) and 1 HA (HA-33) 
isolates showed strong plaque formation on 3T3 Py3 with no plaque formation on 3T3 
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(Benjamin 1970). These mutants were called host range nontransforming mutants 
because of their altered host range caused by an inability to transform cells.   
 Host range nontransforming mutants have proven invaluable for discovering viral 
gene functions as well as corroborating with temperature-sensitive mutant experiments.  
The hr-t mutants, like the temperature sensitive mutant ts-3, have also shown an inability 
to demonstrate reduced extracellular protein expression normally associated with 
transformation despite successfully entering the host cell and expressing viral genes 
(Benjamin and Burger 1970).  An interesting observation from experiments with the hr-t 
mutant NG-18 was its ability to grow in a variety of mouse cell types including cells 
transformed by murine leukemia virus as well as cells in a less differentiated state such as 
mouse embryonic fibroblasts.  This meant that host cells did not need an integrated 
polyoma gene or even all of the traits associated with a transformed phenotype to be able 
to support hr-t growth.  The transformed cells that were not good hosts for hr-t mutants 
included cells transformed by SV40 or spontaneously through mutation (Goldman 1975). 
Because of hr-t mutants’ inability to transform cells, they also could not transform rat or 
hamster fibroblasts (Siegler 1975).  These observations are consistent with the current 
understanding that the middle and small t antigens were inactived in hr-t mutants (Hattori 
1979).  Middle and small t antigens are responsible for the transformed phenotype and 
are necessary for the expression of the host factors required for viral DNA synthesis.  
Both embryonic fibroblasts and cells transformed by mouse leukemia virus would likely 
have had such factors expressed at a sufficient level to compensate for loss of middle and 
small t.  Interestingly, despite being unable to transform host cells, hr-t mutants were still 
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able to express Large T antigen and synthesize viral DNA in nonpermissive 3T3 cells 
(Staneloni 1977).        
At the time it was not understood how mutated viral genes prevented 
transformation or where in the viral genome they were located.  Using a technique that 
replaces regions of hr-t virus with wild type sequence via restriction digestion, the 
disrupted region of hr-t mutant NG-18 was rescued when replaced with wildtype 
sequence near the promoter of the transcript expressed at early times.  This same 
approach also revealed the general locations of other temperature sensitive mutants such 
as ts25D (a type of ts-a mutant), ts-3, and ts-1260 as mapping to the distal early region, 
proximal late region, and distal late regions respectively (Feunteun 1976).  It would later 
be understood that the proximal early region mutated in hr-t mutants like NG-18 affected 
the splicing of middle and small t but not Large T antigens (Hattori 1979).   
Another process affected by hr-t mutation is the status of the viral chromatin.  
Previous observations of wild type polyoma have shown that viral chromosomes are 
highly acetylated on histones H3 and H4 (Frearson 1972, Schaffhausen 1976).  This 
acetylation was not observed in hr-t mutants indicating the necessity of host 
transformation for viral chromosome packaging (Schaffhausen 1976).  Results from these 
experiments have been replicated in a number of other hr-t mutants leading to a model of 
hr-t genes inducing host permissivity factors required for transformation, virus growth, 
and acetylation of host histones incorporated into viral chromosomes.  It was later 
determined that small t antigen specifically is responsible for the hyperacetylation of viral 
chromatin in a manner dependent on its association with protein phosphatase 2A (Dahl 
2007). 
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While the mechanism of culturing hr-t mutants and temperature sensitive mutants 
is different, both kinds of mutants have the ability to complement each other when 
infecting the same cell.  Studies of both hr-t and ts-a mutants showed complementation 
for transformation and growth at high ts-a to hr-t ratios.  Complementation between both 
types of mutants is reciprocal in both untransformed mouse 3T3, hamster BHK, and rat 
Y1 cells and at nonpermissive temperatures (Eckhart 1977).  Unlike hr-t mutants, ts-a 
mutants were unable to grow in cells transformed by murine leukemia virus.  These 
experiments indicated that the mutants were defective in different viral early gene 
functions, suggesting multiple functions for viral early genes (Fluck 1977).  Both wild 
type and temperature sensitive mutants at nonpermissive temperatures were shown to 
induce DNA replication in the host cell for multiple rounds while hr-t mutants only 
induced a single round (Schlegel 1978).  Comparisons between polyoma and SV40 
versions of temperature sensitive and hr-t deletion mutants showed that the temperature 
sensitive mutants lose the ability to maintain transformation but not the ability to initiate 
it while polyoma hr-t and SV40 hr-t deletion (dl) mutants are largely unable to initiate 
transformation (Fluck 1979).  Sequence analysis of the hr-t region of a variety of hr-t 
mutants revealed the C terminal region of smaller early gene products, but not the large T 
antigen, were not expressed (Hattori 1979).  Both kinds of mutants can now be 
understood with regards to the viral genes being disrupted.  Loss of Large T antigen 
precludes viral DNA synthesis but not cellular transformation.  Loss of middle and small 
t antigens precludes cellular transformation.  Loss of viral coat proteins either precludes 
completion of a lytic infection, or in the case of ts-3, results in a loss of the ability of 
virus particles to properly uncoat and transcribe viral DNA.          
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e. Transcription 
Study of the transcription of polyoma RNA at different stages of viral infection 
was made difficult by the variability in the onset of virus induced DNA synthesis at the 
individual cell level.  For this reason the DNA replication inhibitor 5-fluorodeoxyuridine 
(FdU) was used to synchronize polyoma-infected cells.  This allowed detection of 
polyoma RNA via hybridization to viral DNA of both low abundance “early” RNA and 
extremely high abundance “late” RNA expressed before and after DNA replication 
respectively (Hudson 1970).  In the presence of DNA replication inhibitor FdU, 
transcription of early RNA was followed by the expression of tumor antigen leading to 
the cell expressing mitogenic factors and increasing the expression of ribosomal RNA 
(Salomon 1977).  This was consistent with a role of early gene products in driving DNA 
replication.     
Analysis of cytoplasmic polyoma RNA from late times in infection resolved 3 
species of RNA, two of which hybridized to the late region and one that covered most of 
the early region (Kamen 1976, Turler 1976).  In vitro translation of the cytoplasmic long 
and short late region RNAs revealed they code for the capsid proteins VP2 and VP1 
respectively (Smith 1976, Kamen 1978).  At early times in infection both nuclear and 
cytoplasmic RNA was shown to be complementary to 40% of the early strand of the viral 
genome with a small amount complementary to the late strand in the nucleus (Acheson 
and Mieville 1978).  At late times nuclear RNA was shown to be complementary to all of 
the late strand and 60% of the early strand while cytoplasmic RNA was only 
complementary to 45% of the early strand and 55% of the late strand.  Taken together 
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this indicated that the smaller cytoplasmic gene products were likely derivatives of the 
larger nuclear RNAs (Beard 1976).  This is remarkable because it was a good example of 
alternative splicing before splicing had been elucidated.  The small size of the viral 
genome coupled with the difference in the percentage of the viral genome hybridized to 
nuclear and cytoplasmic RNA, indicated that some process was changing the length of 
cytoplasmic RNA.     
 Experiments looking at the viral transcripts produced at late times by 
electrophoresis and sucrose gradient centrifugation revealed surprisingly large RNA 
multiple times longer than the polyoma genome that are processed into smaller species 
(Acheson 1971).  Radiolabeled RNA from late times in infection was found to be highly 
resistant to RNase treatment due to self-annealing.  This indicated symmetrical 
transcription of both strands was occurring across the whole genome at late times (Aloni 
1973).  Isolation of polyoma RNA from late times in infection using oligo(dT) cellulose 
chromatography showed approximately 15% of giant transcripts were polyadenylated.  
When treated with the DNA replication inhibitor FdU, late polyoma transcripts no longer 
exceeded the length of the polyoma genome indicating a dependence of giant transcript 
production on DNA replication (Rosenthal 1976).  The presence of giant nuclear viral 
late transcripts with inefficient polyadenylation at late times of infection was confirmed 
using Southern mini-blot hybridization (Birg 1977) and in vitro transcription (Condit 
1977).  The polyadenylation of giant transcripts was found to be consistently on the 3’ 
end of the late region indicating that it was not terminating at various locations (Lev 
1979).  Electron microscopy of giant RNAs hybridized to restriction-digested polyoma 
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DNA containing 91% of the genome showed that the giant transcripts were contiguous 
tandem repeats of the whole genome and not the result of splicing (Acheson 1978).   
Analysis of the 5’ ends of late polyoma mRNAs via Ribonuclease T1 
fingerprinting revealed a variable number of copies of a “late leader sequence” resulting 
from splicing out whole genome sized introns from the giant transcripts (Legon 1979B, 
Treisman 1981A).  The observed difference in the rate of RNA export from the nucleus 
to the cytoplasm between RNA at early times and RNA at late times is consistent with 
giant late RNA precursors undergoing more processing.  At early times radiolabeled 
uridine was seen in the cytoplasmic fractions <6 minutes after it was seen in nuclear 
fractions, while at late times the difference was between 12 to 20 minutes (Acheson 
1981).  This makes sense if there are longer RNAs to process at late times than at early.  
The tandem repeats of late leader sequences were visualized by electron microscopy of 
the loops cause by hybridizing late mRNA to genomic sequence (Zuckermann 1980).   
Complete digestion of viral mRNA with RNase T1, T2, and A, followed by 2D 
electrophoresis revealed a variety of 5’ cap structures (Flavell 1979).  When the cap 
structures were removed and the 5’ ends of late mRNAs were sequenced, they were 
found to have variable sequences upstream of the late leader (Flavell 1980, Cowie 1981).  
The location of the 5’ cap with respect to the viral sequence was found to be dependent 
on the ratio of available nucleotides when transcribed in vitro indicating variability in 
transcription start sites (Cowie 1982).  Comparison between early and late transcription 
in vitro in HeLa whole cell extracts showed early transcripts to be consistently expressed 
but late transcripts showed lower expression than in vivo and the variability in late 5’ 
capping was not observed.  Late transcription was also affected by the concentration of 
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template in vitro (Jat 1982A).  Mapping of the 5’ ends of early strand mRNAs via 
hybridization to a HinfI restriction fragment spanning the noncoding control region 
followed by S1 nuclease digestion of unhybridized strands and electrophoresis showed 
the majority of early mRNAs are principally capped between nucleotides 147 and 152 
with minor species found to be capped in the early coding region.  At late times species 
were found to have 5’ capping occurring further upstream before the origin of replication 
consistent with either a shift in transcription start sites or contamination from giant 
transcripts (Kamen 1982)(Fig. 2).     
Hybridization of the three cytoplasmic late mRNAs to the viral genome protected 
sequences from digestion by S1 nuclease.  This allowed for the precise splice sites of 
VP1, VP2, and VP3 to be determined by comparing hybridization with a variety of 
restriction fragments to the known sequence of the late region (Kamen 1980).   
 
f. Noncoding control region 
The area of the polyoma genome containing the origin of replication, enhancers, 
the early and late promoters, and large T antigen binding sites is called the noncoding 
control region (Fig. 3).  Much of what is understood about this region has come from 
deletion experiments to determine which areas affect transcription efficiency or DNA 
replication.  Comparisons between the sequence of wild type polyoma and mutants 
capable of replicating in embryonic carcinoma cells also revealed key regulatory 
sequences.   
The origin of replication consists of an A-T tract followed by a GC rich inverted 
repeat that is necessary for DNA replication.  GC to AT base substitutions in the GC rich  
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Figure 2. Shift in the transcription start site of the early strand late in infection. 
 
The noncoding control region is shown in black for both early and late times in infection.  
Early strand transcripts are shown in blue, late are shown in red.  The early strand 
transcribes from the TATA box to the right of the origin at early times.  The late strand 
transcribes from the enhancer A region .  At late times the early strand transcription shifts 
back towards the enhancer A region. 
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Figure 3. Enhancers and host transcripton factor binding sites in the polyoma 
noncoding control region 
 
The 4 enhancers of the polyoma noncoding control region A-D are shown on the late side 
of the origin.  The major host transcription factors that bind to the enhancers are also 
shown.  The origin, Large T binding sites, and early and late transcription start sites are 
shown with the A enhancer also functioning as a late transcription initiation site.   
 
(This image was modified from Martelli J Virol 1996)  
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region were found to disrupt DNA replication when they were closer to the center of the 
inverted repeat (Triezenberg 1984).  The introduction of deletion mutations in the 
noncoding control region between the origin and the late coding sequence demonstrated 
the existence of an enhancer element required for efficient expression of early transcripts 
(Tyndall 1981).  When the polyoma transcriptional enhancer was inserted into a plasmid 
containing the rabbit hemoglobin beta-1 gene, it strongly enhanced expression of rabbit 
transcripts over a distance of 1400 bases (de Villiers 1981).  Using the same beta-globin 
plasmid based approach, enhancers from polyoma and SV40 were both tested in mouse 
and primate cells and demonstrated a cell type preference (de Villiers 1982). 
The transcriptional enhancer region was also found to be necessary for DNA 
replication.  Deletion mutants were not only shown to have a strong negative effect on 
DNA replication from loss of the A-T tract but also when a section containing the 
transcriptional enhancer starting 60 bases into the late region and stopping in the middle 
of the late coding region was removed.  The inability of wild-type virus to rescue these 
mutants demonstrated that the missing sequences function in cis (Luthman 1982).  
Plasmids containing a 251 base segment of the polyoma non-coding control region were 
expressed in MOP cells that express polyoma large T antigen to make them permissive 
for polyoma DNA replication.  Mutation analysis revealed three regions necessary for 
polyoma replication, the core consisting of an A/T tract followed by a GC rich 
palindromic sequence, a sequence upstream of the core in the enhancer region called B 
that has no apparent features, and a sequence further toward the late region called A that 
can substitute for B’s role in DNA replication (Muller 1983).  When the polyoma 
enhancer region was removed the virus lost the ability to replicate.  Addition of an SV40  
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or immunoglobulin enhancer both restored DNA replication in cis and altered cell type 
specificity (de Villiers 1984).  Further analysis of the enhancer region found redundant 
enhancer elements also required for DNA replication.  When the region was deleted and 
copies of a 26 base element were introduced only two copies were required to restore 
DNA replication ability irrespective of orientation.  Two additional enhancer domains, C 
and D were also identified (Veldman 1985). 
Embryonal carcinoma (EC) cells were used to study regulation of transcription 
and DNA replication in viral genes because wild-type virus was shown to grow poorly in 
this cell type but could be compared to mutant virus that can express early and late genes 
in EC cells.  EC cells express lower levels of the c-Fos/c-Jun and ets family of 
transcription factors required for viral transcription.  The duplications in the recognition 
sites for these proteins on the viral genome allowed the mutants to compensate for low 
expression levels (Nothias 1993).  These mutants were first isolated from virus that grew 
on EC cells differentiated into fibroblasts and were selected based on their ability to grow 
in undifferentiated EC cells.  The mutants showed the same functionality and host range 
as the wild type and differed only in a 10-50 bp duplication of sequence on the late side 
of the origin in the noncoding control region (Katinka 1980, Katinka 1981, Vasseur 1980, 
Dandolo 1983).  Comparison between the DNase I hypersensitive regions of wild type 
and EC mutant noncoding control regions showed the same DNAse I profile of two 
hypersensitive regions on the late side of the origin despite different sequence, due to a 
GC rich palindrome common to both wild type and mutant that provides protection 
between the two regions (Herbomel 1981).  Each of the hypersensitive regions was found 
adjacent to an enhancer element in both wild-type and mutant virus (Herbomel 1984).   
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When wild-type and mutant virus were both grown in embryonic carcinoma cells, the 
mutants failed to rescue wild-type DNA replication (as indicated by differing restriction 
fragment size length) suggesting the differing sequence in the noncoding control region 
of the mutants was acting in cis (Fujimura 1982).  
 The polyoma A and B enhancers were found to function as binding sites for host 
factors.  When the B enhancer from polyoma was incubated with proteins from the nuclei 
of 3T6 cells, at least two factors called polyoma enhancer B binding proteins 1 and 2 
(PEB1 and PEB2) were found to cause band shifting and protect a GC rich palindromic 
region homologous to immunoglobulin and SV40 enhancers from Dnase I digestion 
(Piette 1985).  Similar attempts to reveal the factors binding to the A enhancer found two 
proteins called polyoma enhancer A binding protein 1 and 2 (PEA1 and PEA2).  PEA1 
was also found to bind to SV40 and c-fos enhancers suggesting it is the same protein as 
the human activator protein 1 (AP-1) (Piette 1987).  A third type of protein was found to 
bind to polyoma enhancer A called PEA3 that cooperates with PEA1 in response to 
upstream oncogene expression but unlike PEA1 is not dependent on c-fos (Martin 1988, 
Wasylyk 1989).  PEA3 was found to be the same as the transcription factors produced by 
the ets-1 and ets-2 proto-oncogenes (Wasylyk 1990).  Interestingly, in addition to 
functioning as an enhancer for early transcription and DNA replication, the PEA1 and 
PEA3 binding sites also facilitate the initiation of late transcription in lieu of a TATA 
binding by the TFIID complex (Yoo 1991).  Another protein, called Enhancer Factor 1A 
(EF-1A), previously shown to bind to the E1A enhancer region in adenovirus, was 
identified through enhancer fragment competition to bind to 1 site in the A enhancer 
domain and 2 sites in the B enhancer domain.  This interaction was shown to be sufficient 
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to stimulate some replication of polyoma in vivo (Bolwig 1991).  The D enhancer domain 
was shown to bind to a common host transcription factor NF-D, which is a member of the 
NF-1 family (Caruso 1990).  This factor was later shown to be the same as YY1, which 
can positively activate transcription of the late promoter (Martelli 1996).  Interestingly, 
YY1 also directly binds to the late protein VP1, suggesting a possible role for VP1 in 
recruiting transcription factors in the upregulation of the late promoter (Palkova 2000).  
The proteins PEA2, PEA3, and NF-D have different effects on the early and late 
promoters under nonreplicating conditions.  All three factors activate early promoter 
transcription in a combinatorial manner while PEA2 and 3 repress late promoter 
transcription in a manner dependent on direct interaction between the two proteins 
(Shivakumar 1998).  
The activity of enhancer binding proteins PEA1 and PEA3 with respect to viral 
transcription and replication has also been shown to be significantly influenced by middle 
and small t antigens.  The host range nontransforming mutants (hr-t) of polyoma fail to 
express middle and small t antigens but compensate for the lack of downstream effects of 
these proteins with a duplication of the A enhancer to rescue some DNA replication 
ability.  When hr-t mutants were treated with the phorbol ester 12-O-
tetradecanoylphorbol-13-acetate (TPA) to stimulate the pathways leading to an increase 
in the expression of PEA1 and PEA3, more of the DNA replication defect was rescued.  
When middle and small t were expressed in the presence of hr-t mutants with and without 
the duplication of the A enhancer the differences in DNA replication between them were 
abolished and replication efficiency was restored (Chen 1995).  In addition to being 
necessary for viral DNA replication, middle and small t antigens are also necessary for 
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increasing late transcription at late times.  When untreated hr-t mutants were compared 
with wild type virus treated with DNA replication inhibitor cytosine β-Arabinofuranoside 
(AraC) after entering the late phase, the wild type still showed higher levels of late 
transcription even with fewer genomes indicating that the reduction in late transcripts is 
not an indirect result of fewer templates from inefficient replication but from a direct 
reduction in late transcription (Chen 2001).  The major pathways activated by middle T 
(Shc, PI3K, and PLCγ), along with small t antigen each additively contribute to the 
upregulation of PEA1 and PEA3 resulting in an increase in both viral DNA replication as 
well as late transcription (Chen 2006).  
On the early side, the deletion of bases 200-400 base pairs before the 5’ cap sites 
resulted in a loss of transforming ability but still produced RNA in vitro.  The TATA box, 
the 5’ cap site, and 90-100 bases of nonspecific spacer sequence are required for efficient 
in vitro transcription of the early region to occur (Jat 1982B).  Deletion mutations on the 
early side from bases 20 to 86 abolished DNA replication in COP5 cells that express 
large T antigen with smaller deletions resulting in proportionally decreased DNA 
synthesis (Katinka 1983).    
These experiments allowed for a mapping of the major functional sequences in 
the noncoding control region.  The origin of replication, the early Large T antigen 
binding sites, the TATA box on the early side but not the late, and the enhancers of 
transcription and replication make up the majority of the sequence.  Understanding of the 
factors that bind to the noncoding control region is important for both identifying causes 
of host cell specificity as well as demonstrating downstream effects of early proteins such 
as Large middle and small t antigens and the transcription factors they activate.       
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g. Tumor antigens 
 The early gene products of polyoma virus are the large, middle, and small tumor 
antigens that are necessary for transformation and DNA replication.  Initial attempts to 
identify the tumor antigens by in vitro translation produced three proteins of ~90kDa, 
60kDa, and 22kDa (Fig. 4).  Unspliced early viral cRNA was unable to translate into 
Large or middle T but could translate into small t, indicating the presence of an intron.  
The sequences downstream of the splice site were found to be on different reading frames 
for each T antigen (Hunter 1978).  Upstream of the splice site all of the tumor antigens 
were found to share a common N terminal sequence (Hutchinson 1978, Smart 1978) 
containing a highly conserved J domain that binds to the 70kDa family of host heat shock 
proteins (Cheetham 1992, Kelley 1994).  Large, Middle, and small T antigens were 
expressed individually in Py-SV40 recombinants and shown by immunofluorescence to 
localize to the nucleus, cell membrane, and both nucleus and cytoplasm respectively (Zhu 
1984).          
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Figure 4. Functional regions of polyoma tumor antigen proteins 
 
All three of the tumor antigens share a J domain in their common N terminal regions but 
differ in their C terminal regions by each splicing to a different reading frame.  Large T 
antigen has a nuclear localization signal and pRb-binding site in the region that is spliced 
out of middle and small t.  Middle T has a hydrophobic region near the C terminus for 
cell membrane localization and a binding site for PP2A at the N terminus that it shares 
with small t.  Middle T has unique binding sites for pp60c-src and can bind Shc, PI3K, 
and PLC-gamma1 when tyrosines 250, 315, and 322 are phosphorylated respectively.    
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i. Large T antigen 
 When the polyoma Large T antigen was expressed alone in fibroblasts from 
mouse and rat embryos, the cells demonstrated an “immortalized” phenotype in which 
they would grow indefinitely in lower serum concentrations but maintained an 
untransformed appearance.  This immortalization also occurred when only 40% of the 
Large T antigen from the N terminal region was expressed indicating this region 
contained the necessary domain (Asselin 1985, Holman 1994, Rassoulzadegan 1983).  
This process was found to be dependent on interaction between Large T antigen and 
retinoblasoma family of tumor suppressor proteins.  When the region of Large T 
necessary for binding to retinoblastoma proteins was mutated, a loss of immortalization 
of rat embryo fibroblasts was observed (Larose 1991).  Viral genomes mutated to 
preclude binding of Large T to retinoblastoma proteins while expressing wild type middle 
and small t antigens still retained the ability to produce a transformed phenotype and 
tumors (Freund 1992).  In vitro coimmunoprecipitation showed polyoma Large T antigen 
forms a complex with both human and mouse retinoblastoma tumor suppressor proteins 
pRB and p107 (Dyson 1990, Pilon 1996).  The pRB binding domain of Large T fused 
with GST was immobilized on glutathione-sepharose beads and shown to bind to in vitro 
translated C terminal domains of pRB and p107, as well as an additional p130 
retinoblastoma protein (Desjardins 1997).   
The downstream effects resulting from the interaction between Large T antigen 
and pRb were found in some cases to be dependent on the conserved DnaJ domain 
common to the N terminal regions of all T antigens in addition to the pRb binding region.  
The DnaJ domain binds to DnaK proteins such as host heat shock chaperone Hsc70 and 
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stimulates ATP hydrolysis (Cheetham 1992).  When Large T antigen was mutated in its 
pRb binding region or its DnaJ domain, the two mutants were unable to complement each 
other for downstream effects related to E2F promoter activation, suggesting a role for 
direct Hsc70 binding to facilitate Large T interactions with pRb (Sheng 1997).  Despite 
this, Large T mutated in J domain binding to Hsc70 still demonstrated the ability to 
induce apoptosis in differentiating myoblasts, activate the cyclin A promoter, and alter 
phosphorylation of pRb and p130 (Sheng 2000).          
 Unlike SV40 Large T antigen, which was found to bind to the p53 tumor 
suppressor protein (Lane 1979, Linzer 1979), polyoma Large T antigen does not bind 
directly (Wang 1989).  Expression of polyoma Large T antigen in mouse embryo 
fibroblasts with a temperature sensitive p53 produced the same loss of downstream 
effects of p53 (such as expression of p21 and hypophosphorylation of Retinoblastoma 
proteins) as nonpermissive temperatures.  This loss of downstream effects was not 
observed when Large T mutated in its ability to bind retinoblastoma was expressed, 
indicating a dependence on the binding of Large T to pRb to overcome the effects of p53 
and prevent apoptosis or inhibition of DNA replication (Doherty 1997).  In essence, the 
expression of functional Large T antigen in these cells had the same effect on 
downstream targets of p53 as temperature sensitive p53 at nonpermissive temperatures.          
Immunopurified Large T antigen was found to bind to three regions of the viral 
genome between the origin of replication and the early coding sequence.  Each of the 
binding regions contain repeats of the sequence G(A/G)GGC (Cowie 1984, Dilworth 
1984).  Large T mutants unable to bind to the polyoma genome still retained the ability to 
immortalize rat embryo fibroblasts (Cowie 1986).  Like SV40 Large T, polyoma Large T 
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was also found to function as a helicase to unwind double stranded DNA.  Unlike SV40 
Large T, polyoma Large T is able to unwind DNA of sequence unrelated to the polyoma 
origin of replication in vitro if the ratio of Large T to DNA is 100:1 (Wang 1991).  The C 
terminal region of Large T antigen consisting of residues 264-785 was found to be 
sufficient for DNA replication but required complementation with the N terminal region 
to immortalize cells and replicate under low serum conditions (Gjorup 1994).   
Using coimmunoprecipitation and GST pulldown, polyoma Large T antigen was 
found to bind to a subspecies of p300 with histone acetyltransferase activity (Nemethova 
1999), which along with CBP is known to regulate genes that respond to cyclic AMP 
(Arany 1994, Arany 1995, Eckner 1994, Lundblad 1995).  This association was found 
through a region of Large T with a high level of homology to SV40 Large T and 
Adenovirus E1A proteins previously shown to bind to p300/CBP (Arany 1995, Eckner 
1996).  Polyoma Large T was also found to bind to CBP at the N terminal Domain (1-
771) and one of the middle domains (1069-1892) and p300 at the N terminal (1-596) and 
C terminal (1572-2370) domains in a manner independent of p53, NFkB, or ability to 
bind to pRb (Cho 2001).  This demonstrates an additional way Large T can stimulate cell 
cycle progression besides binding directly to retinoblastoma proteins.      
Polyoma mutants able to grow in cancer cells but not in normal cells expressed 
Large T with a C terminal region deficient in binding to the DNA replication inhibitor 
p150Sal2 (Li 2001).  p150Sal2 is a tumor suppressor gene that binds to the promoters of the 
p53-regulated, p21 and BAX tumor suppressor genes and stimulates their expression 
independently of p53 to inhibit DNA replication and cell division (Li 2004).  The gene 
products of the SALL2 gene including p150Sal2 are involved in driving serum-starved 
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cells into a quiescent state (Liu 2007).  This suggests the binding of Large T antigen to 
p150Sal2 in addition to binding pRb is related to the ability of Large T to drive replication 
even in low serum conditions.   
These interactions demonstrate a variety of roles for Large T antigen in the viral 
lifecycle of interacting with both the viral genome and cellular factors involved in cell 
cycle progression.  Large T can immortalize cells and inhibit downstream effects of p53 
by binding to the retinoblasoma family of proteins, prevent serum starved quiescence, 
and bind to the viral genome to function as a helicase in viral DNA replication.  
 
ii. Middle T antigen 
 The polyoma middle T antigen is the primary driver of the transformed phenotype 
in host cells (Ito 1980).  When virus expressing only functional middle T was expressed 
in rat cells, a transformed phenotype was still observed, indicating that middle T is 
necessary and sufficient for cellular transformation (Treisman 1981B).  Middle T 
contains a hydrophobic C terminus that anchors it to the cell membrane (Ito 1977, Ito 
1979, Silver 1978).  When middle T was truncated at the C terminus and expressed with 
wild-type Large and small t antigens, it no longer localized to the cell membrane and the 
transformed phenotype was no longer observed (Carmichael 1982).  Middle T is 
associated with the cell membrane on the inner side and does not possess ATP-binding 
activity (Schaffhausen 1982). 
Immunoprecipitates of polyoma T antigens demonstrated the ability to 
phosphorylate middle T on tyrosine residues (Eckhart 1979).  Through a series of 
deletion mutations, middle T was found to be phosphorylated on a tyrosine at residue 315 
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(Schaffhausen 1981).  This activity was the result of an association between middle T and 
the cellular kinase pp60c-src (Courtneidge 1983, Bolen 1984, Balmer-Hofer 1985), pp62c-
yes (Kornbluth 1987), or pp59c-fyn (Horak 1989).  When the tyrosine at residue 315 was 
mutated to phenylalanine to preclude phosphorylation, middle T showed a dramatic 
reduction in ability to induce a transformed phenotype (Carmichael 1984).  The extent of 
transformation of rat F-111 cells by inducibly expressed middle T was found to correlate 
more with the level of phosphorylated middle T rather than the total amount of middle T 
expressed (Raptis 1985).  Analysis of middle T peptides digested with trypsin and 
phosphorylated in vitro with radiolabeled phosphates revealed a second major 
phosphorylation site at tyrosine 250 (Hunter 1984).  Antisera against the region of middle 
T containing tyrosine 315 still showed phosphorylation at tyrosine 250, while antisera 
against middle T in general showed additional phosphorylation at tyrosine 322 in vitro 
(Harvey 1984).  Unlike phosphorylation of 315, phosphorylation of tyrosine 322 was 
found to be dispensable for transformation (Magnusson 1981, Schaffhausen 1985).  
Immunoprecipitates made with antisera to Middle T antigen not defective in 
transformation were shown to have a phosphatidylinositol kinase activity in vitro and in 
vivo, while middle T mutants defective in transformation did not (Whitman 1985, Kaplan 
1986).  This demonstrated a dependence of middle T transformation on 
phosphatidylinositol metabolism.  When 3T3 cells were either treated with platelet 
derived growth factor (PDGF) or transformed with polyoma middle T, to stimulate the 
phosphorylation of proteins on tyrosine, anti-phosphotyrosine immunoprecipitates 
included an 81-85 kDa phosphoprotein that coincided with high phosphatidylinositol 
kinase activity (Kaplan 1987).  The protein was found to complex with middle T and 
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pp60c-src (Courtneidge 1987) in a manner dependent on the phosphorylation of tyrosine 
315 on middle T (Talmage 1989).  This protein was called phosphatidylinositol-3-kinase 
(PI3K) for its ability to phosphorylate phosphatidylinositol at the D-3 position (Whitman 
1988).  Polyoma transformed 3T3 cells show PI3K activity in the form of elevated 
phosphatidylinositol-3-phosphate, phosphatidylinositol-3,4-bisphosphate, and 
phosphatidylinositol trisphosphate that is not observed in uninfected cells (Serunian 
1990).     
In addition to the 85 kDa PI3K protein associated with middle T, a 61-63 kDa and 
a 36-37 kDa protein were found in complex with polyoma middle T, polyoma small t, or 
SV40 small t antigens (Pallas 1988).  These proteins were identified as the A (regulatory) 
and C (catalytic) subunits of the serine and threonine Protein Phosphatase 2A (PP2A) 
respectively (Pallas 1990, Walter 1990).  PP2A associates with both middle and small T 
antigens through their common N terminal regions, upstream of the splice site, that 
mimic the cellular B subunit.  Biochemical analysis revealed that the association of 
middle T with PP2A is necessary for binding of pp60c-src and related proteins (Campbell 
1995).  Inhibition of the phosphatase activity of PP2A with okadaic acid reduced PP2A 
association with middle T as well as the amount of pp60c-src bound to middle T (Glover 
1999).  Interestingly, mutations causing inactivation of the catalytic activity of the C 
subunit of PP2A precluded interaction with the cellular regulatory B subunit but did not 
preclude association with middle T or recruitment of pp60c-src (Ogris 1999).  This 
suggested that the reduction in association of PP2A with middle T in the presence of 
okadaic acid was not purely the result of a loss of catalytic activity. 
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The Src homology 2 containing protein (Shc) was found through 
immunoprecipitation experiments to bind to middle T antigen in a manner dependent on 
phosphorylation of middle T at Tyrosine 250 at the NPTY motif.  This association results 
in the phosphorylation of Shc by pp60c-src, leading to the binding of Shc by Grb2, 
mimicking the signaling cascade of a tyrosine kinase associated growth factor receptor 
(Campbell 1994, Dilworth 1994).  Shc consists of three isoforms of 46, 52, and 66 kDa 
(Pelicci 1992).  Shc is phosphorylated on tyrosines 239/240 as well as on tyrosine 313 
(Salcini 1994, Gotoh 1996).  Grb2 binds to Shc at either of the phosphorylated tyrosine 
sites and associates with Sos1 or Gab1 (Nicholson 2001). Sos1 is a guanine nucleotide 
exchange factor that converts inactive Ras-GDP to active Ras-GTP resulting in the 
activation of Raf and the MAP Kinase signaling pathway.  Gab1 is involved in the 
localization of Sos1 to the cell membrane where it can interact with Ras-GDP (Yamasaki 
2003).     
Investigation into the role phosphorylation of middle T at tyrosine 322 plays 
revealed the amino acids immediately downstream of tyrosine 322 (Leu323-Asp324-
Ile325) constituted a common binding target of the SH2 domain of Phospholipase C 
gamma 1 (PLC-γ1).  Immunoblotting of middle T immunoprecipitates with anti-PLC- γ1 
antibody showed the presence of PLC-γ1 in a manner dependent on the presence of 
tyrosine 322 (Su 1995).  This association allows for PLC-γ1 to be phosphorylated by 
pp60c-src, which is necessary to activate PLC-γ1 function.  PLC-γ1 catalyzes the 
hydrolysis of phosphatidylinositol 4,5-bisphosphate into inositol 1,4,5-trisphosphate (IP3) 
and diacylglycerol (DAG), each of which activates calcium release and Protein Kinase C 
(PKC) respectively (Majerus 1990).       
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iii. Small t antigen 
The small tumor antigen is nearly identical to the N terminal region of middle T 
and differs only by 4 amino acids downstream of the splice site that terminate on a 
different reading frame.  Like middle T, polyoma small t binds to the A and C subunits of 
protein phosphatase 2A (Pallas 1990, Walter 1990).  Despite both containing the same 
PP2A binding sequence, small and middle T antigen produce different effects when 
binding PP2A.  Small t antigen was shown to produce cell cycle progression by 
associating with PP2A.  When middle T mutated in its ability to associate with PI3K and 
Shc was expressed, it was unable to promote cell cycle progression despite retaining a 
wild-type PP2A association (Mullane 1998).  Expression of both small and Large T 
antigens results in the induction of S-phase and an increase in cyclin A and cyclin E-
specific protein kinase activity.  Small t antigen mutated in its ability to associate with 
PP2A was unable to prevent the protein p27Kip1 from inhibiting cyclin E-specific activity 
(Schuchner 1999).  Small t is also involved in overcoming p53 dependent growth arrest 
and apoptosis.  While Large T antigen does not bind p53 directly in polyomavirus-
infected cells, small and middle T antigens have been shown to resist apoptosis in p53-
induced cells through PP2A and PI3K respectively (Qian 2000).  In mouse primary cells 
and rat embryonic fibroblasts, middle T expression is sufficient to activate the ARF-p53 
pathway (Lomax 2001) but coexpression of small t with an intact PP2A binding site is 
sufficient to overcome the effects of p53 to produce a transformed phenotype (Moule 
2004).  Polyomavirus small t and a mutated form of middle T that does not localize to the 
cell membrane (and thus cannot interact with Src family kinases) both activate the MAP 
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kinase cascade via PP2A in a manner independent of Shc-Grb-Sos activation of Ras 
(Rodriguez-Viciana 2006).  The hyperacetylation of viral chromatin also depends on 
small t directing the host cell to S phase during viral chromosome synthesis and 
packaging (Dahl 2007).  
 
B. Polyoma Virus Life Cycle 
1. Virus Attachment and Entry 
 The life cycle of polyomavirus begins with the attachment of the VP1 viral coat 
protein to the sialic acid component of the ganglioside surface receptors GD1a and GT1b 
on the target host 3T3 cell membrane (Chen 1997, Tsai 2003).  The attachment of VP1 to 
the cell initiates a signal transduction cascade resulting in an initial increase in the 
expression of genes like c-myc and c-fos to prime the cell for DNA replication (Zullo 
1987).  The virus particles enter the host cell through smooth monopinocytic vesicles and 
localize to early endosomes and the endoplasmic reticulum (Griffith 1984, Richterova 
2001, Mannova 2003, Liebl 2006).  Once it arrives in the ER, the hydrophobic C terminal 
domain of the capsid protein VP1 is exposed by the actvity of ERp29, allowing the virus 
to cross the ER membrane into the cytoplasm or nucleus (Magnuson 2005).  The 
chaperone protein Hsp70 is involved in the disassembly of the virus, removing all of the 
coat proteins except the VP1 proteins associated directly with the viral genome in a 
manner similar to histone H1 (Chromy 2006).  The remaining VP1 proteins are necessary 
to direct the viral chromatin to the nucleus via their nuclear localization signals (Li P 
2001).  The protein PARP-1 removes the remaining VP1, revealing the viral enhancers 
	  40	  
and promoters and allowing for the transcription of the early genes to begin (Carbone 
2006).   
 
2. Early Phase 
 Once transcription of the viral genome begins the virus expresses primary 
transcripts from both strands with efficient transcription termination at the overlapping 
polyadenylation sites (Hyde-DeRuyscher 1988, Gu 2009).  This causes the transcripts on 
the late strand to destabilize because the late leader exon at the 5’ end of the late region 
requires at least one read-through of the entire viral genome to splice properly (Adami 
1989, Hyde-DeRuyscher 1990).  The early strand primary transcripts are alternatively 
spliced to make mRNAs for the Large T, middle T, and small t antigens, which localize 
to the nucleus, plasma membrane, and nucleus plus cytoplasm, respectively (Soeda 1980, 
Zhu 1984).  
 The N terminal region of the Large T antigen binds to the Retinoblastoma family 
of tumor suppressors including pRb, p107, and p130, causing the release of E2F 
transcription factors which control the expression of cell cycle genes (Dyson 1990, Pilon 
1996, Desjardins 1997).  This interaction is believed to be facilitated by the DnaJ domain 
that interacts with host DnaK chaperone proteins like Hsc70 (Cheetham 1992, Sheng 
1997).  This domain is common to all three T antigens but is primarily utilized by Large 
T.  Large T also associates with the proteins p300/CBP that function as histone 
acetyltransferases and transcriptional coactivators that bind to cell cycle transcription 
factors such as the Cyclic AMP Response Element Binding protein (CREB) and facilitate 
the recruitment of the transcription complex to express cell cycle genes (Arany 1994, 
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Arany 1995, Eckner 1994, Lundblad 1995, Nemethova 1999).  In addition to promoting 
cell cycle gene expression, Large T also binds to the tumor suppressor p150Sal2, which is 
involved in inhibiting DNA replication by activating the transcription of downstream 
targets of p53 such as p21 and BAX (Li 2004).       
 Middle T antigen localizes to the cell membrane and functions as a consitutively 
active receptor tyrosine kinase to activate signaling cascades resulting in the host cell 
acquiring a transformed phenotype.  The N terminal region of middle T binds to the A 
and C subunits of protein phosphatase 2A by mimicking the B subunit (Pallas 1990, 
Walter 1990).  This association allows for middle T to be phosphorylated by pp60c-src 
(Courtneidge 1983) at a number of locations including tyrosines 250, 315, and 322 
(Harvey 1984, Hunter 1984, Schaffhausen 1981).  Once these sites are phosphorylated 
they become functional binding sites for a number of major signaling proteins.  
Phosphorylation of tyrosine 250 allows for the binding and phosphorylation of Shc 
leading to the activation of the MAP kinase cascade (Campbell 1994, Dilworth 1994).  
Phosphorylation of tyrosine 315 allows for the binding of the 85kDa subunit of 
phosphatidylinositol-3-kinase (Talmage 1989).  This results in phosphorylation of 
phosphatidylinositol leading to activation of PDK1 and subsequently, Akt resulting in 
survival and proliferation (Meili 1998).  The phosphorylation of tyrosine 322 allows for 
the binding and phosphorylation of PLC-gamma, activating its catalytic function causing 
it to cleave PIP2 into IP3 and DAG leading to the release of calcium and the activation of 
Protein Kinase C and downstream oncogenes (Su 1995).  It is the sustained combined 
activation of these pathways that give the cell its transformed phenotype.   
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 Small t antigen functions, primarily, by binding to PP2A in a manner similar to 
middle T (Pallas 1990, Walter 1990).  Unlike middle T, small t localizes to the cytoplasm 
and nucleus allowing for more direct association with PP2A and any targets not bound to 
the cell membrane.  While the precise mechanism of action is unclear, the association of 
small t antigen with PP2A affects a number of cell processes such as promoting cell cycle 
progression (Mullane 1998, Rodriguez-Viciana 2006) and interfering with tumor 
suppressors such as p53 (Qian 2000, Moule 2004) or p27Kip1 (Schuchner 1999).        
The combined activity of the three T antigens results in the host cell entering S 
phase and the activation of host transcription factors results in the expression of proteins 
required for the virus to replicate.  The C terminal region of Large T binds directly to the 
viral genome at the noncoding control region between the origin of replication and the 
early transcription start site (Cowie 1984, Dilworth 1984).  Large T antigen facilitates 
replication of the viral genome by recruiting host replication factors and functioning as a 
hexameric DNA helicase (Wang 1991).       
 
3. Early-Late Switch 
 Once the host enters S phase and viral DNA replication occurs the virus 
undergoes an early-late switch where the expression of late-strand transcripts increases 
more than 50 fold relative to early-strand transcripts (Kamen 1975, Piper 1979, Hyde-
DeRuyscher 1988).  The onset of viral DNA replication correlates with an increase in A-
to-I editing of viral RNA by a class of enzymes called Adenosine Deaminase Acting on 
RNA (ADARs) (Gu 2009).  ADAR enzymes are abundant nuclear and cytoplasmic 
proteins that bind double-stranded RNAs with a preference for A-rich regions and 
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catalyze a deaminating reaction that alters adenosine bases to inosines (Bass 2002).  The 
polyadenylation signals (AAUAAA) of polyoma early and late transcripts overlap 
completely resulting in A-rich regions on both strands when they hybridize.  Whether 
hybridization occurs between transcripts from the same or different DNA molecules is 
unknown but appears to be dependent on viral DNA replication (Liu 1993).  It is the 
editing of the polyadenylation signal that is hypothesized to result in a loss of 
polyadenylation efficiency leading to the giant transcripts observed at late times 
(Acheson 1971, Gu 2009).   
While the 3’- and 5’-splice sites flanking the late-leader exon are strong, the 3’ splice 
sites for VP3 and VP1 are weaker.  This makes leader-to-message body splicing 
relatively inefficient, thus favoring the stronger leader-to-leader splicing in multigenomic 
length precursors (Batt 1994).  The loss of polyadenylation efficiency results in an 
approximately 50% chance a given transcription complex will terminate resulting in the 
observation of primary transcripts as large as 12-15 times the length of the viral genome 
(Acheson 1984, Hyde-DeRuyscher 1990).  Splicing priority is given to the 3’ splice site 
of the late leader resulting in all of the full genome introns between late leaders being 
spliced out and only the last 5’ splice site splices to form VP1 or VP3, or retains the 
intron to form VP2.  This process yields VP1, VP2, or VP3 mRNAs with a number of 
tandem repeats of the late leader sequence corresponding to the number of times the 
transcription complex read through the polyadenylation site before terminating (Fig. 5) 
(Hyde-DeRuyscher 1990).  Interestingly, while the late leader exon itself contains 
sequences complementary to the 3’ end of mouse 18S ribosomal RNA (Soeda 1980) as 
well as binding sites for the 40S ribosomal subunit (Legon 1979A), the actual sequence 
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appears dispensable for virus viability and predominantly serves as a spacer (Adami 
1986).  When the sequence of the late leader was replaced with a different sequence 
lacking complementarity to the mouse 18S ribosomal RNA, it showed no difference in 
translational efficiency (Rhee 1989). 
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Figure 5. Leader-to-leader splicing 
 
During the late phase of infection, the efficiency of polyadenylation decreases leading to 
the production of giant multigenome-long transcripts.  The late mRNAs for VP1, VP2, 
and VP3 require the late leader exon to splice across the entire genome length introns at 
least once to prduce stable mRNAs.  The number of late leaders in a given mRNA 
corresponds to the number of times the polyomerase went around the genome. 
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4. Late Phase 
 During the late phase of infection the host cell is rapidly dividing, even at low 
serum concentrations.  After the onset of viral DNA replication late-strand transcripts 
accumulate rapidly and can constitute up to 2% of all the transcripts in the cell (Kamen 
1975, Piper 1979, Hyde-DeRuyscher 1988).  The late genes VP1, VP2, and VP3 are 
expressed at 50 to 100 times the level of early genes and the giant transcripts from both 
strands have the potential to hybridize, resulting in hyper-editing by ADAR across the 
entire viral transcriptome (Gu 2009).  This likely interferes with the early transcripts 
more than the late transcripts because of the multiple genome long introns spliced out of 
late pre-mRNA that are not spliced from the early strand.  These giant introns potentially 
reduce the chances of spliced late mRNA being edited compared to early transcripts.  
VP1 localizes to the nucleus and assembles into viral capsids in a manner 
dependent on calcium activation (Salunke 1989, Montross 1991).  This calcium 
dependence could be part of the reason defects in VP1 encapsidation were observed in 
middle T mutants (Garcea 1989).  If the mutants were unable to properly interact with 
PLCγ and trigger a downstream calcium release, it could have affected VP1 assembly.  
VP2 and VP3 require the presence of VP1 to localize to the nucleus (Delos 1993).  
VP1 and VP2 are able to associate with each other in the cytoplasm and utilize the 
nuclear localization signal of either protein (Cai 1994).  All three late proteins are 
translated in the cytoplasm and associate with Hsc70 before localizing to the nucleus 
(Cripe 1995).  This association is likely necessary to prevent premature capsid assembly 
in the cytoplasm.  VP1 alone is sufficient to assemble ~5kb of DNA into capsids (Gillock 
1997).  VP1, but not VP2 or VP3, binds directly to DNA through the same N terminal 
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region that contains the nuclear localization signal in a manner independent of sequence 
(Chang 1993).  The encapsidation of DNA is dependent on the concentration of viral 
genomes and not on any particular sequence (Spanielova 2014).   
 
5. Host Cell Lysis 
 By 72 hours after the initial infection, 46% of the host cells are necrotic while 
10% are apoptotic (An 2000).  This is unsurprising because of the continued expression 
of early gene products that interfere with a number of apoptotic pathways.  The small 
population of apoptotic cells is potentially the result of the minor viral coat proteins VP2 
and VP3, which have been shown to induce apoptosis when transfected directly 
(Huerfano 2010).  Once the host cell lyses, virus is released and the process starts over 
with attachment to the next host.    
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C. Thesis Objective and Specific Aims 
  
 The goal of this thesis is to describe global changes in transcription observed by 
high throughput illumina sequencing of the total RNA from a polyoma infection.  
Historically polyomavirus has proven invaluable for understanding host tumorigenesis 
through interaction of viral factors with mitogenic pathways.  The virus has also allowed 
for understanding of host transcription and replication factors due to its small size.  
Despite this, a global view of transcription during polyoma infection has yet to be 
observed.  By aligning sequencing reads from either different time points during infection 
or from infected cells treated with or without a DNA replication inhibitor, our lab can 
observe RNA from early and late phases of infection from both the virus and host.  In 
addition, the use of new read sorting pipelines allows for more direct observation of 
hyper-editing predicted from the production of viral giant transcripts from both strands at 
late times that was once difficult to observe using conventional methods.  By seeing the 
changes in viral and host transcription, we can discover new aspects of viral gene 
regulation as well as downstream host effects. 
 
Specific Aim I: Investigate changes in transcription, splicing, and editing of the viral 
transcriptome at a global level 
   Traditional methods of investigating changes in viral RNA expression over the 
course of infection are costly, labor intensive, and have a limited scope.  By using next 
generation sequencing to simulteneously observe changes in viral transcripts across the 
viral genome, it becomes possible to achieve a more global view of processes such as 
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transcription, splicing, and editing.  The Illumina TruSeq Stranded sequencing system 
allows for the creation of strand specific libraries to be sequenced at a depth of over 50 
million reads.  These reads can then be aligned to the viral genome to illustrate the total 
RNA expression levels at both early and late phases of the viral life cycle.  Furthermore, 
reads spanning splice junctions can be used to observe any changes in the relative 
abundance of viral isoforms on each strand.  Finally, using a pipeline recently developed 
by Porath et al (2014), we can sort unaligned reads to find clusters of mismatches with a 
high probability of resulting from A-to-I editing that has been predicted for polyoma 
transcripts but only observed in a limited way.      
 
Specific Aim II: Investigate global changes in coding and noncoding host transcripts 
over the course of a mouse polyomavirus infection. 
 Viral proteins, especially the T antigens, have been demonstrated to show a 
number of significant mitogenic effects on host gene expression.  These mitogenic effects 
result in a number of transcription factors involved in cell cycle control being activated to 
transition the host cell into S phase and initiate DNA replication.  The same sequencing 
approach used for viral transcripts can also be used to observe changes in all of the 
detectable host genes simultaneously.  By aligning reads from total RNA taken from both 
infected and uninfected samples at different time points to the mouse genome, we can 
observe downstream changes in host gene transcription for both coding and noncoding 
RNA.  Both upregulated and downregulated genes can be analyzed based on enrichment 
for common functions as well as predicted transcription factor binding sites to determine 
the types of categories being overrepresented.  This allows for a much broader look at the 
	  51	  
over all changes in the virus infection than could ever be achieved through traditional 
targeted methods.        
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II. MATERIALS AND METHODS 
 
A. Cell Culture and Virus Infection 
 NIH 3T6 mouse fibroblast cells were cultured on 10 cm plates at a density of 
600Kcells/plate in Gibco Dulbecco’s Modified Eagle Medium (11995-065) supplemented 
with 100 units of penicillin/streptomycin, 2mM L-Glutamine, and 5% calf serum.  Cells 
were serum starved in 2% calf serum 1 day before infection to synchronize cell cycles.  
Polyomavirus strain Py59RA was generously provided by Dr. Robert Garcia in 2% 
Medium at 180 million plaque forming units per ml.  Virus was diluted to 15 million 
PFU/ml to infect cells at an MOI of 50 using 2 ml of virus per plate.  Cells were infected 
by removing media and adding 2 ml of virus for 2 hours before being supplemented with 
8ml of 2% media at time point 0.  Mock infections were carried out using 2% medium 
without filtered virus particles.  Total RNA was harvested at 12, 18, 24, and 36 hours 
after infection by removing media, washing with PBS, and adding 4M guanidinium 
isothiocyanate.  For the aphidicolin treated samples, cells were plated at the same density, 
treated with the same media, and infected at the same MOI for 40 and 48 hours.  
Aphidicolin positive cells were treated with media containing 2µg/ml aphidicolin. 
 
B. Preparation of TruSeq™ Stranded Library 
 RNA was isolated by cesium centrifugation through 2 ml of 5.7M cesium chloride 
at 39000 rpm at 20°C for 18 hours and DNAse treated with DNAse 1 from the Ambion 
DNAse I Kit.  1 µg of RNA was used from each sample for library preparation with the 
Trueseq Stranded Total RNA kit from Illumina.  Ribosomal RNA was depleted using 
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rRNA binding beads and the RNA was fragmented and primed with random hexamers.  
First strand synthesis was done using a mixture containing Superscript II and 
Actinomycin D to synthesize RNA dependent DNA and inhibit DNA dependent RNA 
respectively.  Second strand synthesis was done using dUTP instead of dTTP to create 
stranded cDNA.  Libraries were then adenylated at the 3’ end and adaptors containing 
identifier sequences and flow-cell binding sequences were ligated to both ends.  Finally 
the cDNA fragments were amplified for 12 cycles instead of 15.  The Agilent 
Technologies 2200 Tapestation was used to verify library size at ~260bp.  Sequencing 
was done on a HiSeq 2000 by Perkin Elmer. 
 
C.  Analysis 
 All alignments were made using Tophat v 2.0.9, Bowtie 2.1.0, and Samtools 1.19.  
Alignments to polyoma were done using the reference genome for the Py59RA strain of 
polyomavirus for both time course and aphidicolin experiments.  Time course 
experiments consisted of four conditions, for mock infection and four conditions for 
polyoma infection representing 12, 18, 24, and 36-hour time points with three biological 
replicates per condition.  Aphidicolin experiments consisted of two conditions Aphi+ and 
Aphi- with two biological replicates.     
Alignment of timecourse reads to the host genome was done using the reference 
genome from Illumina’s IGENOMES collection, which in turn was taken from USCS 
March 5, 2013.  The annotation file was modified to remove single-base exons due to 
difficulties tophat had in processing them.  Custom scripts were used to postprocess 
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tophat output to produce strand-specific bedGraph files suitable for use on the UCSC 
genome browser.   
Alignment of reads to the viral origin was done using a custom script that rotated 
the genome zero position counterclockwise by 149nt to avoid splitting annotated 
transcripts.  The reads were aligned to the “rotated” reference genome using tophat with a 
new bowtie index and transcriptome index.  A custom script was then used to convert the 
new alignments to the original coordinates and the new alignments were added to the 
original alignments and displayed on the UCSC genome browser. 
Alignment of reads containing tandem repeats of the late leader exon from late 
gene mRNAs that would not align to the viral genome directly was accomplished by 
doing a direct Bowtie1 end-to-end alignment to predefined reference sequences allowing 
for up to 2 mismatches.  Three references contained 42 bases of the 5’ UTR of VP1, VP2, 
or VP3 followed by the 57 base late leader exon and the first 42 bases of the next late 
leader.  One reference contained the last 42 bases of the late leader followed by a full 57 
base late leader followed by the first 42 bases of the transcription start region upstream of 
the late leader exon.  The last reference sequence contained a full 57 base late leader 
flanked by 42 bases of each late leader on either side.  This allowed 100-base reads 
spanning at least one leader-to-leader splice junction that would not align more than once 
to the same reference sequence to align.        
A to G mismatches were identified using custom scripts that split the fastq reads 
into smaller 25nt fragments and filtered out any that could align to the mouse genome.  
The remaining fragments were aligned to the Py59RA genome using Bowtie1, allowing 
for up to 3 mismatches.  Another custom postprocessing script was used to interpret 
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bowtie alignment output format and scan mismatch fields for canonical editing 
substitutions.   
The hyper editing scripts from Porath et al. 2014 were downloaded and run in the 
context of our cluster pipeline.  Custom scripts were used to extract infromation from 
output files, summarize, and plot as tracks on the UCSC genome browser.   
The relative expression of host genes between time course Mock and PyV 
infected samples was determined using Cuffdiff v 2.1.1.  Dispersion method pooled and 
dispersion method per condition were used to compare individual replicates and all 
replicates of a given condition.  Custom scripts were used to post process/ filter cuffdiff 
output to produce time-series instances of significant logFoldchange.  Cluster 3.0 was 
used to produce a k-means clustering of time course gene expression.  Genes with a log2 
fold change of +/-0.75 representing a 1.5 fold change with an fpkm greater than or equal 
to 1 were used for gene ontology and transcription factor prediction.   
Gene ontology analysis was done using the browser-based application DAVID 
(Database for Annotation, Visualization, and Integrated Discovery)( 
http://david.abcc.ncifcrf.gov/home.jsp).  Gene lists of upregulated and down regulated 
genes were each run against a Mus musculus background and gene categories with a false 
discovery rate below 1E-03 were used with redundant categories removed.      
Transcription factor binding prediction was done using the browser-based application 
Transfind (http://transfind.sys-bio.net/).  The same gene lists of up and down regulated 
genes were used with a 1000nt promoter set (800nt upstream and 200 nt downstream 
TSS) with 1000 genes with the highest predicted factor afinities to take. The TRANSFAC 
(highest info content for each factor) setting was used to represent the factors. 
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III. RESULTS 
 
A. RNA expression in NIH 3T6 cells infected with the Py59RA strain of mouse 
polyomavirus. 
 
 Mouse NIH 3T6 cells were serum starved to partially synchronize their cell cycles 
and then infected without (mock infection) or with filtered Py59RA virus (PyV) at a 
multiplicity of infection of 50.  Total RNA was harvested at 12, 18, 24, and 36-hours post 
infection from three biological replicates for each condition and was used in the synthesis 
of stranded cDNA sequencing libraries using the Illumina TruSeq Stranded Total RNA 
Sample Preparation Kit.  This resulted in libraries ~260 base pairs in length (Fig. 6).  The 
libraries were sequenced using the Illumina HiSeq 2000 platform using paired end reads 
of 100 bases in the forward and reverse directions.  Sequencing data were aligned using 
TopHat and normalized transcript abundance was calculated in fragments per kilobase of 
exon per million fragments mapped (FPKM) using Cufflinks.  Significant differences 
between the virus and mock infections at each time point were determined using Cuffdiff.  
Each condition had three biological replicates producing 10-50 million 100 base reads 
with close to 80% aligning to the host genome and over 1% aligning to the viral genome 
by 36 hours post infection (Table 1). 
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Figure 6. Library Sizes 
 
Libraries used for sequencing were run on Agilent Technologies 2200 Tape Station to 
verify library size.  Libraries were made from 3 biological replicates of mock and PyV 
infected samples at 12, 18, 24, and 36 hour time points.  The average size of the libraries 
was 260 bases. 
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Table 1.  Viral RNA splicing events during infection 
 
Number of aligned reads spanning viral splice junctions during the time course across 
three biological replicates.  Percentages shown are with respect to total early or total late 
splice junction alignments 
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Total 
Reads 
Paired Alignment to 
Mouse Genome 
Paired Alignment 
to Polyomavirus 
Genome 
Mock 12_1 43,640,510 34,532,713 (79.1%) - 
Mock 12_2 13,407,044 10,084,100 (75.2%) - 
Mock 12_3 20,726,081 14,381,090 (69.4%) - 
Py 12_1 44,588,864 33,353,378 (74.8%) 1,710 (<0.01%) 
Py 12_2 21,230,860 18,103,847 (85.3%) 1081 (<0.01%) 
Py 12_3 22,857,265 18,115,603 (79.3%) 1239 (<0.01%) 
Mock 18_1 43,100,950 33,496,251 (77.7%) - 
Mock 18_2 15,771,155 12,276,902 (77.8%) - 
Mock 18_3 12,835,580 9,826,513 (76.5%) - 
Py 18_1 43,139,743 32,662,054 (75.7%) 96,334 (0.22%) 
Py 18_2 26,910,215 21,803,365 (81.0%) 44,146 (0.16%) 
Py 18_3 14,252,449 10,824,627 (75.9%) 29,203 (0.20%) 
Mock 24_1 40,147,080 32,936,666 (82.0%) - 
Mock 24_2 21,984,888 16,516,224 (75.1%) - 
Mock 24_3 21,103,516 16,094,651 (76.3%) - 
Py 24_1 50,787,902 40,004,936 (78.8%) 612,197 (1.2%) 
Py 24_2 23,365,973 18,637,909 (79.8%) 356,237 (1.52%) 
Py 24_3 22,087,645 17,404,983 (78.8%) 409,726 (1.86%) 
Mock 36_1 44,049,053 35,120,311 (79.7%) - 
Mock 36_2 20,282,845 17,153,722 (84.6%) - 
Mock 36_3 16,873,257 9,811,783 (58.2%) - 
Py 36_1 41,028,401 28,135,319 (68.6%) 600,650 (1.46%) 
Py 36_2 16,629,665 11,053,515 (66.5%) 314,095 (1.89%) 
Py 36_3 9,748,905 5,795,074 (59.5%) 198,156 (2.03%) 
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B.  The polyomavirus transcriptome. 
 In order to visualize changes in viral transcripts at different time points during 
infection, we used Bowtie and Top Hat to align sequencing reads to a Py59RA reference 
genome (Fig. 7).  At 12 hours after infection, reads mapped to both early and late strands, 
but with most representing early-strand expression.  While this is consistent with a model 
where the early promoter dominates before the onset of viral DNA replication (Kern 
1986), it could also be consistent with a model in which the early-late switch is dependent 
on relative transcript stability rather than on regulation of transcription initiation (Hyde-
DeRuyscher 1988).  By 18 hours after infection viral replication has commenced and the 
infection is entering the late phase.  At this point, there is an approximate 100-fold 
increase in reads aligning to the late strand and these transcripts are beginning to 
dominate over early-strand transcripts (Fig. 8).  Also of note at this time is the appearance 
of a significant number of transcripts that extend beyond the late polyadenylation site, 
representing multi-genomic late-strand transcripts (Acheson 1971, Gu 2009).  While most 
fully polyadenylated and spliced late RNAs are cytoplasmic (Kamen 1976, Acheson 
1978), these giant RNAs are nuclear and serve as precursors to late mRNAs (Turler 1976, 
Flavell 1977, Acheson 1978).  By 24 and 36 hours after infection the number of late 
strand alignments increases to around 1000 fold compared to early times.  We note that at 
late times the majority of fully processed viral mRNAs have accumulated in the 
cytoplasm (Kamen 1975, Beard 1976, Hyde-DeRuyscher 1990). 
While the relative levels of early-strand and late-strands change dramatically 
during infection, we noted no significant changes in patterns of RNA splicing, but did 
observe several interesting and unexpected changes to early-strand RNA accumulation  
	  62	  
Figure 7. Py59RA reference sequence 
 
5‘ splice sites are indicated in blue.  3‘ Splice sites are indicated in red.  The late leader 
exon is shown with the black box.   The early poly(A) site shown with a blue box.  The 
complement of the late poly(A) site is shown with a red box. 
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Figure 8. Alignment of the time course reads to the Py59RA genome (unscaled) 
 
NIH 3T6 cells were infected with Py59RA at an MOI of 50 or with a mock infection.  
Total RNA was harvested at 12, 18, 24, and 36 hours and stranded cDNA libraries were 
prepared for sequencing on the HiSeq 2000 sequencer.  Reads were aligned to the 
Py59RA genome and visualized on the UCSC genome browser.  Time course reads 
aligned to the Py59RA genome unscaled to show differential expression between early 
(top blue) and late (bottom red) strands. 
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during infection.  First, it is clear that, relative to the bulk of early-strand RNAs, there is 
elevated alignment to a roughly 200 base pair region just downstream of the early 
polyadenylation site (Fig. 9).  This peak was not seen when DNA replication and the 
early-late switch is blocked by aphidicolin (Fig. 10).  In this experiment, mouse NIH3T6 
cells were infected with Py59RA virus in the same manner as the time course except they 
were treated with either the same media or media with 2 µg/ml of the DNA replication 
inhibitor aphidicolin to prevent the infection from entering the late phase (Liu 1993).  
The infected samples, both treated and untreated, were incubated for 40 and 48 hours 
before RNA was collected for stranded cDNA library synthesis using the same protocol 
as the time course.  This allowed sufficient accumulation of early gene products without 
the untreated samples reaching the lysis phase of the viral life cycle.  Results were only 
aligned to the viral genome since aphidicolin treatment would likely cause significant 
alterations to the host transcriptome.   
These reads appear to result from poly(A) site read-through and are antisense to 
VP1. While we do not yet know why or how they accumulate, one possible explanation 
would be that they represent precursors for viral-encoded microRNA(s).  Polyomavirus 
and SV40 have previously shown viral expression of microRNAs antisense to Large T 
antigen, which were hypothesized to help avoid a cytotoxic T cell response (Sullivan 
2005, Sullivan 2009).  Alternatively, the increase in sequences from this region could 
result from uneven processing/degradation of early-strand transcripts that have read 
through the early polyadenylation site. 
The second unexpected change in early-strand RNA alignments during infection 
is in the early promoter/origin/noncoding control region.  We originally noted changes in  
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Figure 9. Alignment of the time course reads to the Py59RA genome (scaled) 
 
NIH 3T6 cells were infected with Py59RA at an MOI of 50 or with a mock infection.  
Total RNA was harvested at 12, 18, 24, and 36 hours and stranded cDNA libraries were 
prepared for sequencing on the HiSeq 2000 sequencer.  Reads were aligned to the 
Py59RA genome and visualized on the UCSC genome browser.  Time course reads 
aligned to the Py59RA genome scaled to show changes in early strand alignment.  Top 
blue strand is early, bottom red is late.  The transcription start site can be seen shifting 
across the origin to the far right on the early strand.  In addition a peak can be seen on the 
early strand downstream of the polyA site in the center between 3200 and 3500 bases. 
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Figure 10. Alignment of 48 hour aphidicolin + and - reads to Py59RA genome.  
 
NIH 3T6 cells were infected with Py59RA at an MOI of 50 or with a mock infection and 
treated with or without the DNA replication inhibitor aphidicolin at a concentration of 
2µg/ml (5.9µM).  Total RNA was harvested at 48 hours and stranded cDNA libraries 
were prepared for sequencing on the HiSeq 2000 sequencer.  Reads were aligned to the 
Py59RA genome and visualized on the UCSC genome browser. (A) Samples of 48 hr 
infections with and without the DNA replication inhibitor aphidicolin to block the 
initiation of late phase aligned to the Py59RA genome unscaled to show differential 
expression between early and late strands.  (B) Scaled to show changes in early strand 
alignment. 
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alignments to the edges of our reference genome.  By aligning the reads to a linearized 
reference genome shifted by about 150 bp, we were better able to visualize the nature of 
these molecules, which span the replication origin.  As infection proceeds, there is a clear 
increase in the alignment of early-strand reads to the origin of replication and enhancer 
region, strongly suggesting a potential upstream shift in early-strand transcription start 
sites during infection, and particularly after the onset of viral DNA replication (Fig. 7).  
We note that even at late times after infection in the aphidicolin treated samples, this shift 
is not observed (Fig. 8).  Such a shift from a strict early transcription start site 
downstream of a canonical TATA box at early times (e.g., the 12 hour time point) to 
variable upstream transcription start sites at late times was suggested previously to 
explain confounding results obtained by S1 nuclease experiments (Kamen 1982).  
Mapping of the hybridization of 5’ ends of cytoplasmic early-strand transcripts at late 
times to a region of the polyoma genome containing the noncoding control region and 
part of the early region showed an apparent increase in usage of upstream start sites 
(Kamen 1982). 
 
C. Splicing analysis 
 Using TopHat to map the splice junction reads we were able to determine the 
relative expression levels of the 5 viral isoforms that contain splice junctions (Table 2).  
At 12 hours post infection the mRNA for large T represents 75% of early-strand mRNAs, 
with mRNAs for middle T and small t accounting for 20% and 5%, respectively.  We also 
note that a fourth early mRNA, for “tiny T antigen” encoding just the DnaJ domain 
(Riley 1997) has been reported and this is seen in our data, although this message is of  
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Table 2. Viral splicing events during infection 
 
Number of aligned reads spanning viral splice junctions during the time course across 
three biological replicates.  Percentages shown are with respect to total early or total late 
splice junction alignments. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	  73	  
 
 
 
 
 
 
 
 
 Large T middle T small t tiny t VP1 VP3 
12 Hours       
Rep 1 50 (75.8%) 
13 
(19.7%) 
3    
(4.5%) 
0  
(0%) 
46 
(88.5%) 
6  
(11.5%) 
Rep 2 40 (74.1%) 
9  
(16.6%) 
5  
(9.3%) 
0  
(0%) 
20  
(80%) 
5  
(20%) 
Rep 3 72 (87.7%) 
8  
(9.8%) 
2  
(2.5%) 
0  
(0%) 
12  
(80%) 
3  
(20%) 
18 hours       
Rep 1 589 (62.9%) 
175 
(18.7%) 
172 
(18.4%) 
0  
(0%) 
2735 
(89.6%) 
319 
(10.4%) 
Rep 2 354 (69.3%) 
82  
(16%) 
75 
(14.7%) 
0  
(0%) 
1058 
(77.3%) 
311 
(22.7%) 
Rep 3 250 (69.6%) 
58 
(16.2%) 
51 
(14.2%) 
0  
(0%) 
863 
(80.9%) 
204 
(19.1%) 
24 Hours       
Rep 1 1686 (64.2%) 
559 
(21.2%) 
380 
(14.4%) 
6  
(0.2%) 
41245 
(90.2%) 
4133 
(9.1%) 
Rep 2 788 (63.1%) 
237 
(19%) 
218 
(17.4%) 
7  
(0.5%) 
14203 
(80%) 
3553 
(20%) 
Rep 3 1074 (65.1%) 
306 
(18.5%) 
262 
(15.8%) 
10  
(0.6%) 
17825 
(79.6%) 
4570 
(20.4%) 
36 hours       
Rep 1 1822 (63.7%) 
589 
(20.6%) 
442 
(15.4%) 
10  
(0.3%) 
39525 
(90.2%) 
4294 
(9.8%) 
Rep 2 630 (59.5%) 
250 
(23.6%) 
169 
(16%) 
10  
(0.9%) 
16453 
(78.3%) 
4555 
(21.7%) 
Rep 3 408 (60.6%) 
162 
(24%) 
97 
(14.4%) 
7  
(1%) 
11087 
(80.1%) 
2760 
(19.9%) 
	  74	  
very low relative abundance.  As infection proceeds, the ratios of large, middle and small 
T antigen mRNAs change little, indicating that early strand splicing is likely not 
regulated strongly by viral or host proteins that change during infection.  Like early 
mRNAs, late splicing patterns do not change dramatically during infection, although the 
absolute numbers of alignments increase up to 1000 fold, consistent with the strong 
upregulation of late gene expression. 
 
D. Leader-to-leader splicing. 
 Owing to the presence of tandem repeats of late leaders in all three late mRNAs, 
alternative reference sequences were required to capture reads that span at least one 
leader-to-leader splice junction (Table 3).  The stranded cDNA libraries produce 2x100 
base pair reads.  The late leader exon is 57 bases long so we required a reference 
sequence that captured reads that extended at least 1 base past the first leader-to-leader 
splice junction both downstream and upstream of the late leader on VP1, VP2, and VP3 
cDNA as well as the late transcription start sites.  We used a reference sequence 
containing 42 bases upstream of the late leader exon near the transcription start region 
followed by a full late leader exon and the first 42 bases of the next late leader (Table 3 
bottom of first column).  We also used a reference sequence of the last 42 bases of late 
leader, a full late leader, and the first 42 bases of late leader to capture ambiguous leader 
to leader reads from any mRNA crossing at least 2 leader to leader splice junctions 
(Table 3 bottom of second column).  Reference sequences containing the last 42 bases of 
a late leader followed by a full late leader and 42 bases of the 5’ UTR of VP1, VP2 or 
VP3 (Table 3 bottom of third, fourth, and fifth columns).  Leader-to-leader splices were  
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Table 3. Alignment of reads from late leader repeats.   
 
The 100 base reads from time course and aphidicolin samples were realigned to custom 
reference sequences containing at least one leader to leader splice junction.  The 
reference sequences were 5 variations of a 42-57-42 base splice of late leader exons to 
each other, the transcription start site, or the 5‘UTR of VP1-3.  The number of reads 
aligning to each reference sequence for each condition is shown. 
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only seen at significant levels in time points later than 18 hours and in cells untreated 
with aphidicolin, supporting the model that leader to leader splicing occurs after DNA 
replication. 
 
E. A-to-I editing of viral RNAs. 
 Due to the read-through of early and late transcripts at late times, as well as the 
genomic overlap of the early and late polyadenylation signals, there is the possibility that 
if complementary sequences accumulate near one another in the nucleus, they might form 
double stranded RNAs.  As nuclear dsRNAs can be promiscuously edited by ADAR 
enzymes, which deaminate adenosines to inosines (Bass 2002), viral dsRNAs should also 
exhibit this fate.  We have reported previously that this is indeed the case (Kumar 1997, 
Gu 2009), but the current study allowed us to examine viral RNA editing in more 
comprehensive detail, which was done in two ways.  Since inosine base pairs like 
guanosine, we first looked for individual A-G mismatches in the read alignments to 
search for potential sites for editing.  We divided the 100 nucleotide reads into four 25-
nucleotide fragments and allowed up to three base mismatches during the alignment step 
(Zhu 2013).  After filtering for any sequences that aligned to the mouse genome, we 
realigned the sequences to the viral genome to show regions of A-G mismatches (Fig. 
11).  Such alignment cannot be conclusive for RNA editing, as it could merely reflect 
sequencing or alignment errors.  Indeed, this sort of analysis, when applied to other base 
transformations, generated similar, though less robust data.  We therefore examined viral 
regions where A-G mismatches greatly outnumbered mismatches caused by any other 
base changes.  The most striking region associated with A-G changes was the 
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 Figure 11. Reads with up to 3 A-G mismatches as potential ADAR editing sites.  
 
Reads from the time course run were broken from 100 bases to 25 bases and realigned 
with a threshold of 3 mismatches allowed per 25 base read.  Reads with A-G mismatches 
were visualized using the UCSC genome browser to indicate regions with potential 
editing sites.  The polyadenylation sites showed the highest number of A-G mismatched 
reads at late times of infection.     
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overlapping polyadenylation region, which showed a much higher rate of A-G mismatch 
compared to other combinations (Table 4).  This was not surprising since the 
polyadenylation region has previously shown to be edited at late times during infection 
(Gu 2009).  
 
As long dsRNA is subject to hyperediting, where up to 50% of the adenosines are 
converted to inosines (Kumar 1997), it is quite likely that the above analysis missed 
much or most of the editing that occurs during polyomavirus infection.  In order to 
capture a greater fraction of hyper edited reads that may have been omitted due to having 
too many A-G mismatches we used a method recently described by Porath et al 2014.  
These authors developed a pipeline that sorts unaligned reads based on whether they fail 
to align due to a specific type of mismatch and whether such mismatches occur in the 
types of clusters associated with hyperediting.  The first step was to align all the reads to 
the mouse genome to reduce the total number of reads and remove most non-viral 
sequences.  Second, we aligned the remaining reads to the viral genome and discarded 
any that aligned perfectly or with few mismatches.  Third, we transformed all As in both 
the reads and the reference genome to Gs and discarded any transcripts that did not align.  
This allowed us to only sort for reads that initially had A to G mismatches.  Fourth, the 
mismatches were clustered based on predictions for known A-I editing including adjacent 
sequences and only reads that clustered in a manner consistent with A-I editing were 
kept.  Finally the bases that were members of clusters were displayed on the UCSC 
genome browser (Fig. 12).  Results showed a time dependent increase in the number of 
bases that were members of hyperedited clusters, with a large concentration of such 
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 Table 4. Single base mismatches across the polyoma genome.   
 
Base to base mismatches from the 36 hour time point found in the 25 base read 
alignments allowing for up to 3 mismatches.  Mismatches in and around the poly(A) sites 
show the highest number of A to G mismatch.  Early and late poly(A) sites in bold.  Each 
position represents both strands. 
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Figure 12. Accumulation of hyper-editing clusters during the time course.   
 
Reads from the time course were aligned with the host mouse genome and discarded.  
Reads were then aligned to the Py59RA reference genome and discarded.  A’s in reads 
that did not align to the Py59RA genome were changed to G’s and realigned to a Py59RA 
reference genome that itself had all A’s changed to G’s.  This allowed for reads that did 
not originally align to the unalteredt Py59RA genome due to hyperediting to be captured.  
The process was repeated for all combinations of single base mismatch.  Clusters of A-G 
mismatches from the time course consistent with hyperediting by ADAR were mapped to 
the Py59RA genome. 
 
 
 
 
 
 
 
 
 
 
 
 
 
	  84	   
	  85	  
clusters around the overlapping polyadenylation sites.  No significant editing was 
detected in aphidicolin treated samples (data not shown).  Together, these data are 
consistent with our previously reported polyoma editing results (Heiser 1982, Gu 2009).  
Shortly after the early late switch at 18 hours we see the polyadenylation region (and a 
cryptic poly(A) site in the early region, just downstream of the stop codon for middle T 
antigen) showing editing clusters.  As the infection progresses the number and size of the 
clusters increases on both strands.  This is consistent with editing resulting from early and 
late strand hybridization since the over abundance of late sequence compared to early 
would only produce more clusters if the late strand formed hairpins and was edited in cis.  
Editing clusters can also be seen in the noncoding control region suggesting that multi-
genome length giant transcripts are capable of annealing with one another.  While editing 
has long been predicted due to the long antisense transcripts and poly(A) read-through, 
this is the first time we have had direct evidence of genomewide editing at late times.  We 
note, however, that while editing is readily and abundantly observed, we cannot conclude 
from these data whether it is a cause or a consequence of viral gene regulation. 
 
F. Effects of viral infection on host gene expression.   
 Our deep sequencing data allowed us to not only examine viral gene expression 
during infection, but also changes in the host transcriptome that result from the infection.  
Using Cuffdiff to compare gene expression between polyomavirus and mock infected 
samples, we found 1,216 genes were differentially expressed at least 1.5 fold across all 
three replicates with 359 genes upregulated and 857 genes downregulated compared to 
the mock infections at the 36 hour time point (Table 5). 
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Table 5. Number of host genes dfferentially expressed between mock and Py59RA 
infected samples 
 
The number of host transcripts that changed more than 1.5 fold across all three biological 
replicates was determined using Cuffdiff.  Only genes with expression >1 fpkm were 
counted. 
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 12 hours 18 hours 24 hours 36 hours 
Upregulated 0 6 12 359 
Downregulated 0 7 19 857 
Total 0 13 31 1,217 
	  88	  
We used the database for annotation, visualization, and integrated discovery 
(DAVID) (http://david.abcc.ncifcrf.gov/) to determine the gene ontology of the 
differentially expressed genes that were significantly enriched based on common 
biological function (Table 6).  We also selected genes of high abundance with a strong up 
or down regulation between mock and virus infected cells at 36 hours for validation by 
RT-qPCR (Fig. 13 and 14). 
 For the upregulated genes the categories with the highest enrichment included 
transcripts coding for ribosomal proteins, chromatin binding proteins, DNA replication, 
RNA processing, and mitochondrial proteins.  These are all consistent with the known 
increase in growth and metabolism induced by the combined action of the early genes.  
For example, the transcript for Hist1h1a that codes for the histone 1 linker involved in 
compacting DNA during replication (van Holde 1988) is upregulated more than 2 fold in 
infected cells by 36 hours (Fig. 15).  The transcript for the mitochondrial inner membrane 
protein Timm8a1 that is involved in the insertion of cytoplasmic proteins into the 
mitochondrial inner membrane (Paschen 2000) is also upregulated.  Another interesting 
observation is the transcript coding for the JunB component of AP-1 transcription factors 
is upregulated.  This is of interest because JunB was originally understood to function as 
an antagonist of the AP-1 protein c-Jun, which is involved in cell cycle progression (Chiu 
1989, Schutte 1989).  Later observations found this interaction to be more complex and 
sensitive to cell type and context (Shaulian 2002). 
 Downregulated genes were enriched in categories such as GTPase regulation, cell 
adhesion, actin cytoskeleton, extracellular matrix, and transcription regulation.  One of 
the more strongly downregulated transcripts included Col1a2 (Fig. 15) which codes for  
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Table 6. Gene ontology analysis  
 
The web based application Database for Annotation, Visualization and Integrated 
Discovery (DAVID) was used to sort lists of significantly upregulated or downregulated 
genes (>1.5 fold) from the 36 hour time point by common function and enrichment using 
the Mus musculus background.  A false discovery threshold of 1E-03 was used. 
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 Gene Count 
% of 
upregulated 
genes 
P-value Fold Enrichment FDR 
Upregulated      
Ribosomal 
Protein 38 11.95 3.60E-30 12.86 4.65E-27 
RNA  
Processing 31 9.75 3.29E-10 3.9 5.19E-07 
Chromosomal 
Protein 19 8.5 1.19E-11 8.37 1.53E-08 
Mitochondrial 
Protein 42 13.2 9.30E-11 3.18 1.20E-07 
DNA  
Replication 18 5.66 2.16E-09 6.51 3.41E-06 
Ribosome 
Biogenesis 14 4.4 1.13E-07 6.87 1.79E-04 
Pyrimidine 
Metabolism 16 5.03 1.50E-09 7.59 1.55E-06 
Downregulated      
GTPase 
Regulator 58 6.98 1.19E-16 3.49 1.67E-13 
Cell  
Adhesion 61 7.34 8.60E-10 2.35 1.52E-06 
Actin 
Cytoskeleton 32 3.85 7.04E-10 3.66 9.73E-07 
Chromosome 
Organization 44 5.29 2.70E-07 2.36 4.76E-04 
Embryonic 
Development 48 5.77 1.70E-08 2.47 2.99E-05 
Transcription 
Regulation 158 19.01 8.99E-09 1.53 1.59E-05 
Urogenital 
Development 27 3.25 2.60E-09 4 4.59E-06 
Cell  
Motion 44 5.29 1.73E-08 2.59 3.05E-05 
Extracellular 
Matrix 39 4.7 3.69E-09 2.96 5.09E-06 
Pathways in 
Cancer 42 5.05 5.53E-10 2.9 6.27E-07 
Zinc  
Finger 93 11.2 4.90E-08 1.79 6.79E-05 
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Figure 13. Validation of upregulated genes.  
 
One noncoding and three coding genes with a high expression and at least 1.5 fold 
change were selected for validation of upregulated genes by qPCR.  FPKM results shown 
in left cloumn.  qRT-PCR results shown in the right column.   
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Figure 14. Validation of downregulated genes.   
 
One noncoding and three coding genes with a high expression and at least 1.5 fold 
change were selected for validation of downregulated genes by qPCR.  FPKM results 
shown in left cloumn.  qRT-PCR results shown in the right column. 
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Figure 15. Example of host protein coding transcripts significantly upregulated or 
downregulated in infected samples compared to mock infection.   
 
Protein coding reads from the time course were aligned to the host genome. (Left) 
Expression of Hist1ha increases compared to mock infection. (Right) Col1a2 decreases 
compared to mock infection. 
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one of the polypeptide components of Collagen type 1 that makes up the extracellular 
matrix (Vuorio 1990).  Another strongly downregulated transcript encodes the steroyl-
CoA desaturase 2 (Scd2) enzyme that catalyzes the synthesis of monounsaturated fatty 
acids, increasing membrane fluidity (Ntambi 1999).  Unlike in polyoma infection, Scd2 
has been shown to be upregulated in other cancer cells and may be responsible for 
inducing hepatocellular carcinomas (Muir 2013).  It is unclear how the virus would 
benefit from a reduction in monounsaturated fatty acid synthesis.  The transcript for the 
protein myristolylated alanine-rich C-kinase substrate (Marcks) that is involved in 
altering the actin cytoskeleton (Laux 2000), cell motility (Brooks 1996), and functions as 
a tumor suppressor (Bickerboller 2015) was originally shown to be downregulated in 
mouse 3T3 fibroblast cells expressing v-Src (Joseph 1992).  Our data also show 
significant down regulation of this transcript. 
 In addition to coding RNAs, we observed significant changes in the expression of 
noncoding RNAs (Table 7, Fig. 13 and 14).  The noncoding small nucleolar RNA Snhg1 
was highly expressed and significantly upregulated (Fig 16).  Snhg1, also known as the 
host gene for U22, is expressed from an intron and is required for processing of 18S 
ribosomal RNA (Tycowski 1994).  This is consistent with the increase in the expression 
of genes involved in ribosome biogenesis and translation in polyoma infected cells.  
Another noncoding RNA, Metastasis Associated Lung Adenocarcinma Transcript 1 
(MALAT1), was significantly downregulated in infected cells (Fig. 16).  Though the 
precise function of MALAT1 is still unclear, it has been shown to be involved in a 
variety of metastatic cancers (Ji 2003).  Its downregulation is consistent with the 
downregulation of other genes involved in cell motility in polyoma-infected cells. 
	  98	  
Table 7.  Significant changes in noncoding RNAs.   
 
List of noncoding RNAs by name, feature type, and fold change log2 ratio that change 
more than 1.5 fold between Mock and PyV infected samples by 36 hours after infection.   
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Upregulated 
Noncoding RNA Feature Type 
Fold Change Log2 
Ratio 
1600020E01Rik lincRNA  gene 1.406401543 
2410006H16Rik Unclassified ncRNA gene 1.091248082 
3300005D01Rik lincRNA  gene 1.682985052 
Gm11974 Unclassified ncRNA gene 1.685511363 
Gm12603 lincRNA  gene 2.060374312 
Rmrp RNase MRP RNA gene 1.78468046 
Rpph1 RNase P RNA  gene 2.765659453 
Rprl3 RNase P RNA  gene 2.656127479 
Scarna13 snoRNA  gene 1.048926376 
Snhg1 Unclassified ncRNA gene 1.389978478 
Terc Telomerase RNA gene 1.669975844 
Downregulated 
Noncoding RNA   
2900097C17Rik Unclassified ncRNA gene -0.81491907 
Gm13375 Unclassified ncRNA gene -1.242099564 
Malat1                                       lincRNA  gene -1.412442083 
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Figure 16. Example of host noncoding transcripts significantly upregulated or 
downregulated in infected samples compared to mock infection.  
 
Noncoding RNA reads from the time course were aligned to the host genome. (Left) 
Expression of Snhg2 increases compared to mock infection. (Right) Malat1 decreases 
compared to mock infection. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	  101	   
	  102	  
Taken together, these observations illustrate a change in priority of infected cells 
from cell-to-cell interaction, movement, and signal transduction to growth, metabolism, 
and DNA synthesis. 
 Do differentially expressed genes share common patterns of regulation that may 
help to explain their response to viral infection?  In order to determine common 
transcription factor binding sites upstream of differentially expressed genes we used the 
Transfind tool (http://transfind.sys-bio.net/) to determine common transcription factor 
binding sites among the differentially expressed genes (Kielbasa 2010).  Using a 
threshold of binding motifs common to the upstream regions of <1000 genes (out of 
33,837 genes in the mouse database) and a false discovery rate <0.02, we found a number 
of common transcription factor binding sites (Table 8 and 9).  As expected the promoters 
of upregulated genes were the most enriched for binding sites of the transcription factor 
E2F, which is a major cell cycle regulator that is released and activated by the binding of 
Large T antigen to pRB (Bracken 2004).  Binding sites for members of the CREB-ATF 
family of transcription factors were also enriched in the upregulated gene set.  This is 
consistent with CREB Binding Protein (CBP) and EP300 being targets for large T 
antigen, resulting in CRE containing promoters being activated (Goodman 2000).  The 
nuclear factor kappa B (NFkB), which has been previously shown to be involved in 
inflammation, transformation, proliferation, angiogenesis, and metastasis shows binding 
sites upstream of the upregulated genes (Aggarwal 2004).   Interestingly, STAT1, which 
is involved in signal transduction of the interferon pathway, appears to have a common 
binding site among a number of the upregulated genes.  While the interferon pathway 
does not appear to be active (pathway genes were not noted to be strongly up or down  
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Table 8. Transfind transcription factor prediction for 36 hour upregulated.  
 
The web based application Transfind was used to predict common transcription factor 
binding sites among the lists of upregulated and downregulated host genes.  Predictions 
of mouse transcription factor binding sites were made with promoter sets of 1000nt from 
800nt upstream to 200nt downstream and compared with 1000 genes with the highest 
predicted factor affinities among 33,837 total mouse genes.  Possible factors were 
represented by the TRANSFAC matrix. 
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Factor p-value FDR FP # of genes + 
# of 
genes  
- 
Back 
ground 
+ 
Back 
ground  
- 
E2F <1.00E-07 3.00E-09 9.00E-09 45 331 955 32882 
NF-Y 2.74E-07 1.49E-05 5.94E-05 31 345 969 32868 
HIF1 8.45E-07 3.06E-05 1.83E-04 30 346 970 32867 
GABP 2.52E-06 6.83E-05 5.46E-04 29 347 971 32866 
CREB 
ATF 2.52E-06 6.83E-05 5.46E-04 29 347 971 32866 
STAT1 2.00E-05 4.34E-04 4.34E-03 27 349 973 32864 
CREB 2.00E-05 4.34E-04 4.34E-03 27 349 973 32864 
CREBP1 5.32E-05 8.25E-04 1.16E-02 26 350 974 32863 
ATF4 5.32E-05 8.25E-04 1.16E-02 26 350 974 32863 
AHR 5.32E-05 8.25E-04 1.16E-02 26 350 974 32863 
NFkB 7.88E-04 1.07E-02 1.71E-01 23 353 977 32860 
YY1 7.88E-04 1.07E-02 1.71E-01 23 353 977 32860 
ATF2 
CJUN 1.78E-03 1.93E-02 3.86E-01 22 354 978 32859 
C-REL 1.78E-03 1.93E-02 3.86E-01 22 354 978 32859 
IRF1 1.78E-03 1.93E-02 3.86E-01 22 354 978 32859 
ATF3 1.78E-03 1.93E-02 3.86E-01 22 354 978 32859 
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Table 9. Transfind transcription factor prediction for 36 hour downregulated.  
 
The web based application Transfind was used to predict common transcription factor 
binding sites among the lists of upregulated and downregulated host genes.  Predictions 
of mouse transcription factor binding sites were made with promoter sets of 1000nt from 
800nt upstream to 200nt downstream and compared with 1000 genes with the highest 
predicted factor affinities among 33,837 total mouse genes.  Possible factors were 
represented by the TRANSFAC matrix. 
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Factor p-value FDR FP # of genes + 
# of 
genes  
- 
Back 
ground 
+ 
Back 
ground  
- 
SP1 <1E-09 3.00E-09 2.60E-08 85 781 915 32432 
WT1 <1E-09 3.00E-09 2.60E-08 82 784 918 32429 
AP2 <1E-09 3.00E-09 9.00E-09 81 785 919 32428 
TFIII <1E-09 3.00E-09 2.60E-08 70 796 930 32417 
MAZ <1E-09 3.00E-09 2.60E-08 69 797 931 32416 
HIC1 <1E-09 3.00E-09 2.60E-08 66 800 934 32413 
KROX <1E-09 3.00E-09 9.00E-09 64 802 936 32411 
AHRHIF 6.00E-09 1.10E-07 1.21E-06 58 808 942 32405 
MZF1 3.40E-08 6.15E-07 7.39E-06 56 810 944 32403 
MAZR 2.22E-06 3.44E-05 4.82E-04 51 815 949 32398 
HES1 2.22E-06 3.44E-05 4.82E-04 51 815 949 32398 
SPZ1 4.82E-06 6.97E-05 1.05E-03 50 816 950 32397 
EGR1 1.02E-05 1.31E-04 2.22E-03 49 817 951 32396 
MTF1 1.02E-05 1.31E-04 2.22E-03 49 817 951 32396 
EGR2 2.13E-05 2.43E-04 4.61E-03 48 818 952 32395 
ZIC1 2.13E-05 2.43E-04 4.61E-03 48 818 952 32395 
ZIC2 4.32E-05 4.69E-04 9.38E-03 47 819 953 32394 
AHR 8.60E-05 8.48E-04 1.87E-02 46 820 954 32393 
USF 8.60E-05 8.48E-04 1.87E-02 46 820 954 32393 
CACCCBF 1.67E-04 1.58E-03 3.63E-02 45 821 955 32392 
HIF1 3.18E-04 2.76E-03 6.90E-02 44 822 956 32391 
SMAD4 3.18E-04 2.76E-03 6.90E-02 44 822 956 32391 
PAX3 1.07E-03 8.31E-03 2.33E-01 42 824 958 32389 
NRF1 1.07E-03 8.31E-03 2.33E-01 42 824 958 32389 
AP2a 1.07E-03 8.31E-03 2.33E-01 42 824 958 32389 
USF 1.90E-03 1.42E-02 4.12E-01 41 825 959 32388 
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regulated during infection), the fact that many upregulated genes share the potential to be 
affected by it is of interest. 
	  108	  
IV. DISCUSSION 
 
We have presented here a global view of polyomavirus infection with respect to 
both the virus and the host transcriptomes.  The data and analyses have allowed us to 
generate a detailed picture of how viral gene expression changes throughout the life cycle 
as well as to learn how infection impacts host cell gene expression.  We analyzed RNA 
from a number of individual time points, from relatively early in infection (12 hours post 
infection) to late times (36 hours post infection) but before extensive cytopathic effects 
were noted.  Although there were several surprises, the expression and processing of viral 
transcripts was generally consistent with previous literature.  At early times in infection, 
early-strand transcripts dominated over late-strand transcripts.  This early pattern is even 
more dramatic when DNA replication is blocked with aphidicolin and the infection 
allowed to proceed for 48 hours.  At early times, most of these transcripts appear to 
initiate at a defined site and terminate just downstream of the annotated early 
polyadenylation signal.  These are spliced to produce mRNAs for the three viral early 
proteins, large, middle and small T antigens.  However, by 18 hours, after large T antigen 
has promoted the onset of viral DNA replication, the pattern of expression reveals a 
striking shift toward the late phase, where late-strand RNAs greatly dominate over early-
strand RNAs.   This early-to-late switch is characterized by several distinct and important 
changes in the pattern of alignments in our data.  First, as late messages accumulate 
rapidly and genomes replicate, we noted an unexpected shift in the position of the 5’-ends 
of early-strand transcripts.  At late times, early-strand RNAs appear to initiate over a 
broad region upstream of the early TATA box, and throughout the origin of replication.  
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We do not yet know why this is the case or how it is regulated, but these findings are 
consistent with an earlier report in which the 5’-ends were mapped using nuclease S1 
protection (Kamen 1982).  Interestingly, this switch depends on viral DNA replication, 
since after blocking it with aphidicolin, these upstream 5’-ends were not seen, even after 
48 hours.   
Another clear change in early-strand expression, and also dependent on DNA 
replication, was the appearance and accumulation of reads mapping to a region several 
hundred nucleotides downstream of the polyadenylation site.  We do not know the 
genesis of these reads, and they do not appear to be the result of RNA splicing or a 
discrete RNA processing event.  Further studies are needed to determine whether these 
represent discrete RNA species or regions of early-strand transcripts that have extended 
past the polyadenylation site.   
Late-strand transcription and processing also changes during infection.  While 
accumulating to only low levels before viral replication, or in its absence, these RNAs 
accumulate rapidly afterwards, and by late times represent the great majority of viral 
RNAs in the cell.  Their processing may also change with time, although we did not note 
any discernible change in transcription start sites.  As others have reported before, late 
transcription can proceed many times around the circular viral genome, leading to a 
heterogeneous collection of giant transcripts that can serve as precursors to mature late 
mRNAs (Acheson 1971, Aloni 1973, Heiser 1982, Adami 1989, Gu 2009).  Processing 
involves not only alternative splicing to generate messages for VP1, VP2 and VP3, but 
also the splicing of noncoding late leader exons at their 5’-ends.  The number of tandem 
leader units appearing on late mRNAs reflects the number of transits around the genome 
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made by RNA polymerase II before transcription termination and polyadenylation.  We 
noted a striking accumulation of leader-leader splicing events at late times in infection.  
These were only seen at late times, and after DNA replication.   
Late leader splicing requires inefficient late-strand transcription termination and 
polyadenylation.  We have reported previously that this is the result of particular viral 
genomic features in the early/late polyadenylation region (Gu 2009).  These sites overlap 
on the genome and this affords viral transcripts the opportunity to anneal with one 
another, leading to dsRNA in the nucleus.  dsRNA formation could alter  normal 3’-end 
processing by interfering with the polyadenylation machinery.  Also, dsRNA formation 
could lead to promiscuous editing by ADAR1, leading to RNAs that cannot be 
recognized by the processing machinery.  We have previously found that viruses that 
cannot generate early-strand and late-strand transcripts that overlap are incapable of the 
early-late switch (Gu 2009).  The consequences of such dsRNA formation are of 
profound importance for the virus.  Inefficient late-strand termination leads to the 
multigenomic transcripts that serve as precursors to late mRNAs (Acheson 1971, Aloni 
1973, Heiser 1982, Adami 1989).  Early-strand termination is likely also to become less 
efficient, but in this case the multigenomic transcripts are not used for mRNA production, 
but are rather likely degraded in the nucleus owing to unproductive splicing.  Our data 
support these concepts.  While our transcriptomic data reveal mostly the accumulated 
mature mRNAs at late times, close inspection reveals roughly equal levels of poly(A) site 
readthrough transcripts on each strand.  These would be expected to be capable of 
dsRNA formation, leading to ADAR editing.  Indeed, A-to-G mismatches consistent with 
A-to-I editing were observed to only occur at late times in cells untreated with replication 
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inhibitor, with robust editing observed in the overlapping polyadenylation sites.  The 
hyperediting pipeline we employed allowed us for the first time to capture polyoma reads 
that would otherwise be too heavily altered to be identified.  The increase in edited 
clusters aligning along the entire length of the reference genome was predicted but, to our 
knowledge, has never been directly observed until now.  Taken together, these 
observations confirm previous models of the early-late switch that describe a loss of 
polyadenylation efficiency concomitant with an increase in editing of the polyadenylation 
sites resulting in giant multigenomic RNAs, which can be spliced to generate multiple 
late leader exons on late mRNAs. 
Alignment of reads from the time course infection to the host genome showed the 
greatest change between mock and infected samples by 36 hours, allowing us to observe 
the accumulated effects of the virus on the host transcriptome.  We suspect later time 
points might yield more genes changing more than 2 fold up or down but time points 
closer to 72 hours would be entering the lysis phase of the viral life cycle and any 
observed changes would likely be difficult to separate from those associated with host 
cell death.  At 36 hours post infection, we found 359 genes significantly upregulated and 
857 genes significantly downregulated.  Many of the genes upregulated were involved in 
predicted processes such as metabolism, ribosome synthesis, mitochondrial proteins, and 
cell cycle progression.  This is consistent with the action of viral T antigens in stimulating 
the proliferation of host cells.  Many downregulated genes were also largely unsurprising 
with those involved in cell motility, extracellular matrix, and cell signaling processes 
prominent on the list.  Finally, we noted the upregulation or downregulation of several 
abundant long noncoding RNAs.  There are several lncRNAs of particular interest.  One 
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is Malat1 (downregulated), which has been associated with metastasis and which may 
play a role in RNA processing (Ji 2003).  Another is Terc (upregulated), which is 
involved in telomere maintenance and cellular lifespan (Artandi 2010).  Finally, several 
lncRNAs associated with RNAse P enzymes are also strongly upregulated.  We do not 
yet know the significance of this, but such molecules have been implicated in tRNA and 
ribosomal biogenesis, which is consistent with the observed increase in host translation in 
infected samples (Lai 2010).   
Here we have presented for the first time a global analysis of both viral and host 
transcriptional changes from a mouse polyomavirus infection.  The viral transcriptome 
analysis revealed insights into changes in RNA expression, especially with respect to the 
early strand at late times and confirmed a number of previous observations of the 
polyoma lifecycle.  This is the most direct evidence of widespread hyper-editing of viral 
RNA predicted from a model of extensive early and late strand transcription.  The 
observations of changes in host transcription also confirm a number of predictions 
including the increase in genes involved in cell growth, metabolism, and translation.  
Future investigation into more precise aspects of the lifecycle including later time points, 
nuclear and cytoplasmic fractionation, and PolyA plus and minus samples may yield 
further insight into the viral-host interactions. 
 
 
V. FUTURE DIRECTIONS 
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 The observations made by this investigation into the polyomavirus infection offer 
some of the most comprehensive insight into the changes in both viral and host 
transcription.  Despite this, a number of questions still remain.  What kind of differences 
would be observed in nuclear vs cytoplasmic or polyA+ vs polyA- RNA from mock and 
infected samples?  We might expect to see more defined viral alignments consistent with 
mature mRNA in the cytoplasmic fractions and more readthrough from the giant 
transcripts in the nuclear fractions at late times.  PolyA- selection might also reveal more 
noncoding RNAs in the host.  What changes in splicing or editing clusters of host genes 
are observed between mock and infected samples at early and late times?  Perhaps some 
transcripts that are regulated by processes dependent on the presence of double stranded 
RNA are affected by virus infection.  Do the changes in transcription also produce the 
same changes in translation?  We know of a number of post-translational modifications 
that are associated with the signaling pathways activated by viral tumor antigens but a 
more global profile of those changes has not yet been pursued.  What is the precise nature 
of the shift in the 5’ ends of early transcripts at late times?  Is it the result of more subtle 
changes in viral chromatin states beyond initial hyperacetylation?  How does DNA 
replication and the early late switch affect transcription factor binding?  Does the process 
of DNA replication allow transcription factors to better access the late transcription start 
site contained within the A enhancer?  What would happen if the A enhancer was moved 
to the early side of the origin or the Large T binding sites moved to the late?  Is editing a 
byproduct of the fact that viral DNA forms double stranded RNA or is it necessary for 
loss of polyadenylation and subsequent production of giant transcripts?  These are just a 
few of the questions that remain to be investigated. 
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